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ABSTRACT
DAF-19, the only RFX transcription factor found in C. elegans, is required for
the formation of neuronal sensory cilia. Four isoforms of the DAF-19 protein have
been reported, and the m86 nonsense (null) mutation affecting all four isoforms has
been shown to prevent cilia formation. Transcriptome analyses employing
microarrays of L1 and adult stage worms were completed using RNA from daf19(m86) worms and an isogenic wild type strain to identify additional putative DAF19 target genes. Using transcriptional fusions with GFP, we compared the expression
patterns of several potential gene targets using fluorescence confocal microscopy.
Expression patterns were characterized in various genetic backgrounds in order to
determine isoform-specific expression patterns. Additionally, we completed rescue
experiments using cDNAs encoding specific DAF-19 isoforms in a daf-19 null
genetic background. Our data indicate that several new genes are activated by DAF19 in both ciliated and non-ciliated neurons. We are currently developing isoformspecific CRISPR/Cas9 mutants to further explore the precise mechanisms by which
different DAF-19 isoforms regulate their target genes.
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INTRODUCTION
The mysteries of the brain have long been one of the most elusive areas of medicine. As
our understanding of both genetics and anatomy improves, one of the primary questions of
neurobiology asks where these two areas intersect - that is, how does gene expression affect
neuronal function? Recently, the urgency of this question has increased as we uncover evidence
that failures of gene function and regulation underlie many of the most insidious diseases of the
nervous system, including Alzheimer's, Huntington's, and Parkinson's disease. The nematode
model organism Caenorhabditis elegans has proved particularly useful for addressing such
questions, due to its well-mapped connectome and cell lineage.
In the present study, we seek to identify and characterize unknown gene targets of the C.
elegans transcription factor DAF-19, a protein that we believe plays a role in maintaining
synaptic protein levels. Mutants of this gene show various signs of neurodegeneration, which
may prove an effective model for conditions such as Alzheimer's disease. We have found a
variety of novel targets of DAF-19 whose expression patterns in the nervous system are affected
by mutations in this transcription factor. Furthermore, we have evidence that two of the protein's
lesser-understood isoforms may be responsible for the gene's potential role in synaptic protein
level maintenance and neuronal gene expression. The present study seeks to identify and
characterize these targets, and also uses CRISPR/Cas9 genome engineering to develop better
tools with which to understand the isoform-specific functions of DAF-19.
C. elegans as a model organism
Caenorhabditis elegans is a small, free-living roundworm that thrives in rotting
vegetation around the world. Nobel laureate Sydney Brenner first established the use of C.
elegans as a model organism in the 1960s, after a search for a simple eukaryotic system in which
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to study organismal development and the nervous system. Brenner chose C. elegans as his
preferred model organism for several traits that make it uniquely useful for biological research.
The worm is easy to culture thanks to its ability to self-fertilize, its short generation time, and its
capacity to thrive on a food source of E. coli. Genetic manipulations in C. elegans are quite easy
to carry out, as hermaphrodites can either be mated with males or maintained through selfpropagation, following traditional Mendelian genetics. Further genetic changes can be obtained
through mutagenesis screens or the use of site-directed mutagenesis techniques, including
TALENs and the CRISPR-Cas9 system. C. elegans has an entirely transparent body, which
makes it highly useful for anatomical studies, particularly those involving fluorescent imaging of
specific structures (Corsi et al., 2015; Figure 1).

Figure 1: C. elegans anatomy. Lateral views of the adult hermaphrodite (A) and the adult male (B), as well as a
cross section of the adult worm (C). Structures of note include the dorsal and ventral nerve cords (DNC and VNC),
the pharynx, nerve ring, and gonads. Figure adapted from Corsi et al., 2015.
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C. elegans adults are approximately 1 mm in length, and grow from egg to sexually
mature adult in ~3 days when grown at 20o C. The worm has two sexes: hermaphrodites, which
comprise over 99% of wild type populations, and males, which constitute approximately 0.10.2% of the population and occur when meiotic non-disjunction events occur (Corsi et al., 2015).
The hermaphrodite possesses ovotestis which first produce sperm and then oocytes, which are
fertilized from the worm’s own spermatheca. The embryos develop independently of their
mothers within tough eggshells, and are laid at the 24-cell stage; the full embryogenesis process
takes approximately 16 hours at 20o C (Corsi et al., 2015). Once hatched, the worms grow
through four larval stages (L1, L2, L3, and L4) with molts between each, before reaching
maturity (Figure 2). In crowded, food-limited, or otherwise stressful environments, L2 larvae
will forgo the usual developmental path and enter an alternative life stage known as dauer after
the second molt. Dauer worms have no oral opening as the cuticle exoskeleton completely
covers the animal, and they can survive without eating for several months, until a new food
source is found. At this point, the larva will shed its mouth plug and continue development
(Corsi et al., 2015).
C. elegans are particularly useful organisms for the study of developmental processes and
the neuronal connectome, due to their extremely well-mapped and invariant cell lineage. Adult
hermaphrodites have 959 somatic cells, while adult males have 1081 (Sulston & Horvitz, 1977).
Our thorough understanding of this cell lineage has led to a much better picture of the early
events of embryogenesis, including asymmetric cell division and programmed cell death.
Additionally, studies of the connectome have allowed researchers to study the first completely
defined neural network. Adult hermaphrodites contain 302 neuronal cells, many of which
connect to a structure known as the nerve ring, which serves as the animal’s brain (Sulston &
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Horviz, 1977). This connectome is simple enough to have been simulated with robots
programmed to move based on representative nerve connections, which mimic simple nematode
behaviors (Szigeti et al., 2014). Our thorough understanding of the worm’s small nervous
system ultimately provides an excellent model through which to understand the neural functions
of higher order animals.

Figure 2: C. elegans life cycle. Worms mature from embryo to adult over the course of approximately 3 days, after
going through four molts. Starved or otherwise stressed L2 larvae have the capacity to enter the dauer stage, and
can survive without a food source for several months. Image adapted from Corsi et al. (2015).

Figure 3: Head neurons in L1 larvae. Image adapted from wormatlas.org. The tip of the worm’s nose is oriented
to the left, with the two pharyngeal bulbs shown in green.
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The RFX Transcription Factor DAF-19
The C. elegans transcription factor DAF-19 was first identified by Peter Swoboda and
colleagues in 2000. Swoboda found that DAF-19 is an RFX-type transcription factor, so named
for its characteristic DNA binding domain. It is the only known RFX transcription factor in C.
elegans. Swoboda’s research found that daf-19 is expressed in all ciliated sensory neurons, and
that the gene plays a critical role in ciliogenesis, to the point that daf-19 null mutants contain no
cilia. Additionally, daf-19 mutants are dauer constitutive, meaning that all L2 stage worms enter
the dauer pathway regardless of environmental conditions (Swoboda et al., 2000).
RFX transcription factors belong to the winged-helix family of transcription factors, and
were originally identified in the mammalian immune system when the human RFX-1 gene was
found to regulate the Major Histocompatibility Complex class II (MHCII) genes (Reith et al.,
1988). RFX transcription factors control expression of MHCII and other genes by binding the 14
base pair x-box motif found in the target gene's promoter region. RFX transcription factors are
widely conserved, and have been identified in various organisms including humans and mice
(Reith et al., 1993), yeast (Wu & McLeod, 1995; Emery et al., 1996), C. elegans, Drosophila,
Xenopus, and D. Rerio (Emery et al., 1996). They possess a unique DNA binding domain, a
dimerizing domain near the carboxy-terminal end, and a flexible "hinge" region near the amino
terminus (Reith et al., 1990). The human RFX genes are expressed in various tissues, including
(but not limited to) the brain (RFX-1 and RFX-4), the testis (RFX-2 and RFX-4), pancreatic
tissues (RFX-6), the kidneys (RFX-5 and RFX-7), various immune tissues (RFX-1 and RFX-5),
and in some cases in all ciliated cells (RFX-3) (Aftab et al., 2008). These genes play a major
role in ciliogenesis, among other functions, and mutations in these genes have been shown to
cause significant medical conditions called ciliopathies. Studies in mice have demonstrated that
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the RFX3 transcription factor directs nodal cilium development and left-right symmetry
specification, and mutants are highly prone to early embryonic lethality and situs inversus (the
reversal of the left-right organ pattern) (Bonnafe et al., 2004). Other major ciliopathies result
from mutations in RFX genes, such as Bardet-Biedl Syndrome and primary ciliary diskinesia
(Chen et al., 2006; Bonnafe et al., 2004). These pathologies cause a wide variety of symptoms,
ranging from renal failure to chronic bronchial inflammation and sperm defects (omim.org). A
better understanding of the functions of RFX transcription factors is important for understanding
these diseases, many of which are poorly characterized. By studying the function and targets of
DAF-19 in C. elegans, we may be able to identify novel targets that have human homologues,
which may lead us to a better understanding of these disease mechanisms.
One of our primary questions about DAF-19 surrounds its four known splice isoforms.
Senti and Swoboda identified three such isoforms, two of which (DAF-19A and DAF-19B) are
significantly longer than the third (DAF-19C) (Senti & Swoboda, 2008). A fourth isoform
(DAF-19M), found only in male worms, was characterized by Wang et al. in 2010 (Figure 4).
Senti and Swoboda gave the first evidence that DAF-19 expression is not restricted to ciliated
sensory neurons, as was previously reported (Swoboda et al., 2000). They used RNase
protection and N and C-terminal specific antibodies to show that three isoforms of different
lengths occur in hermaphrodite worms, and demonstrated with antibody staining that the short
form DAF-19C isoform is found exclusively in ciliated sensory neurons, while the long form
isoforms A and B are found only in non-ciliated neurons. This finding first suggested that the
long form isoforms might play a role unrelated to ciliogenesis.
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Figure 4: Isoforms of daf-19. Exons are depicted by boxes, and introns are depicted by the connecting lines. The
DNA binding domain (DBD) and dimerization domain (DIM) are both shown, as is the m86 null mutation affecting
all isoforms. Figure adapted from Wang et al. (2010).

Senti and Swoboda further examined the behavioral patterns of daf-19 m86 mutants (null
for all isoforms), and found defects in dwelling and roaming behaviors. When placed on an agar
plate seeded with bacteria, wild type worms alternate between “dwelling” behaviors where they
stay in one part of the plate to feed (about 80% of the time) and “roaming” behaviors” where
they rapidly crossing the entire bacterial lawn (Fujiwara et al., 2002). Senti and Swoboda found
that in m86 null mutants, worms did not show roaming behavior (Figure 5). This is consistent
with ciliary defects, as worms without cilia in their sensory neurons are unable to properly smell
food; thus, they do not seek it out. Interestingly, when Senti and Swoboda performed rescue
experiments with isoform-specific rescue constructs, they found that isoforms A and C were each
able to partially rescue dwelling and roaming behavior, but only worms with a full length
genomic construct containing all three isoforms showed a completely rescued phenotype. This
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suggests that the behavioral defects were not only caused by a lack of cilia, but rather reflect
additional neurodegenerative effects.

Figure 5: Dwelling and roaming assay. Wild type worms (B) show both behaviors, and completely cover the
plate. m86 (D) and che-13 (C) mutants, which prevent cilia growth, fail to roam across the plate. Rescue
experiments with genomic constructs of daf-19C (F) and daf-19A (G) each partially rescue the roaming phenotype,
and the full length genomic construct (E) fully rescues the behavior. Figure adapted from Senti & Swoboda (2008).

Further assays with the paralytic drugs aldicarb and levamisole showed the possibility of
either a presynaptic or postsynaptic defect that affected the worm's ability to process
acetylcholine (a neurotransmitter). Additionally, Senti and Swoboda found decreased expression
of synaptic vesicle proteins in daf-19 mutants, including UNC-64/syntaxin, IDA-1, UNC-17,
SNB-1, and SNT-1. However, none of these proteins appear to be directly regulated by DAF-19,
as each lacks an x-box in its promoter region, and they also showed no difference in transcript
levels between wild type and m86 worms. Thus, while isoforms A and B appear to play a
significant role in maintaining synaptic proteins, they appear to do so indirectly (Figure 6; Senti
& Swoboda, 2008).
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Figure 6: Potential functions of DAF-19 isoforms. Daf-19C is known to regulate ciliogenesis by binding the
x-box sequences of target genes. DAF-19A/B appear to play a role in maintaining synaptic protein levels,
although the mechanism for this is unknown. Figure adapted from Senti & Swoboda (2008).

De Stasio Lab: Past work
Since Senti and Swoboda's 2008 finding that the isoforms of DAF-19 may play different
regulatory roles, our lab has been attempting to determine the targets of and mechanisms by
which this process occurs. Elizabeth De Stasio first completed a microarray comparing relative
gene expression levels across the transcriptome in adult worms that were either wild type or m86
mutants of daf-19. She used worms that had been adults for two days due to their fully
developed cilia, and because the loss of synaptic proteins had been seen most dramatically at this
age (Senti & Swoboda, 2008). Multivariate analysis of the data resulted in a list of 180 genes
with 1.5-fold or greater difference in expression between m86 and wild type worms. From this
list, various genes were chosen for further study based on several criteria, including protein
domains suggesting a neuronal function or expression pattern, the presence of a human ortholog,
or ready availability of mutant alleles. This list complements two additional microarrays
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completed by Prasad Phirke, which examines differential expression in m86 or wild type worms
across the transcriptome in L1 larvae and 3-fold stage embryos. From the three lists, a total of 30
genes were selected for further analysis. Transcriptional fusions with green fluorescent protein
(GFP) were generated for each of these genes, such that a plasmid containing the promoter
region of the gene in question immediately precedes the open reading frame of GFP. An
additional second marker such as mCherry was included in the plasmid as a positive control to
identify transgenic worms. These were injected separately into two lines of worms, one wild
type for daf-19 and one containing the m86 mutation. Since then, we have identified over ten
genes that show visible daf-19 dependence based on these transcriptional fusions, including
several for which gene expression appears to be dependent on one or more isoforms of DAF-19.
CRISPR Mutagenesis
In order to study the different effects of the various isoforms of DAF-19, it is useful to be
able to observe the expression patterns of putative target genes in daf-19 isoform-specific
mutants. As previously stated, our lab currently has several such mutants that have null alleles of
daf-19a and daf-19b; however, we do not yet have any mutants that are specific to daf-19c. Of
course, as all of the exons in DAF-19C are conserved in DAF-19A and DAF-19B, it is
challenging to create a mutant that knocks out only the short isoform without affecting its two
longer cousins. Such potential mutations are highly specific, and would be unlikely to arise from
traditional mutagenesis screens; as such, we have need for a site-directed mutagenesis approach.
Various tools have been described to create such specific mutations, including TALENS, first
identified in 2007 by Römer et al., and zinc finger nucleases, first created by Kim, Cha, and
Chandrasegaran in 1995. Today, the gold standard of genome editing is the CRISPR/Cas9
system, originally described by Jinek et al. (2012).
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CRISPR, or "clustered regularly interspaced short palindromic repeats," is a genetic
feature of some bacteria and archaea that provides adaptive immunity against viruses and
plasmids (Wiedenheft et al., 2012). CRISPRs consist of short repeated elements of
approximately 29 nucleotides separated by 32 nucleotide 'protospacer' DNA. These sequences
contain DNA from viruses or plasmids with which the bacteria has previously come in contact,
and serve as a genetic record of such prior encounters that functions as a kind of genetic vaccine
for the bacteria. In addition to the CRISPR sequences, the bacteria also produce proteins from
the Cas gene family of nucleases, which flank the CRISPR loci (Wiedenheft et al., 2012). When
the CRISPR loci are transcribed, the various Cas proteins can pair with these sequences, which
then recognize their complements in invading viruses or plasmids. The Cas proteins then induce
double strand breaks in the invader's DNA, thus eliminating the threat (Figure 7).
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Figure 7: CRISPR-mediated adaptive immune systems in archaea and bacteria. Various CRISPR systems in
the bacterial genome address invading threats by recognizing viral or plasmid DNA. Figure adapted from
Wiedenheft et al. 2012.

CRISPRs were described as genome editing tools by the Doudna lab, which showed in
2012 that the system can be engineered to produce double strand breaks at nearly any desired
locus (Jinek et al., 2012). Together with Emanuelle Charpentier, Doudna showed that a
CRISPR RNA (called a crRNA) identifies the region of DNA to cleave, known as the
protospacer. This crRNA base pairs to a trans-activating crRNA (tracrRNA), which directs the
Cas protein (in this case Cas9) to the protospacer. Cas9 recognizes a short 5'-NGG-3' motif
adjacent to the protospacer, known as the PAM sequence, which consists of any nucleotide (N)
followed by two guanine nucleotides. The PAM sequence is necessary for Cas9 to bind and
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cleave target DNA. Doudna and colleagues showed that it is possible to engineer a single RNA
chimera containing both crRNA and tracrRNA which can be used to direct Cas9 to cleave DNA
at specific loci as desired. crRNAs can be designed to target nearly any part of the genome, thus
allowing a wide range of mutagenic applications for this technology.
After Cas9 induces a double strand break in the DNA, the body will attempt to repair the
damage by ligating the ends of the broken fragments together through one of two pathways. The
first, non-homologous end joining (NHEJ), was discovered in 1980s. In this pathway, the ends
of the cleaved DNA are resected and then ligated together, and there are often deletions of a few
bases that may affect the function of the gene products. As such, NHEJ is often used to generate
knockout mutants. However, to produce specific mutants, the homologous recombination
pathway can be used to make precise changes in the modified genome (Figure 8). In this
pathway, a similar strand of DNA (for example, on the sister chromatid) is used as a template for
the broken section. In CRISPR mutagenesis, this pathway can be exploited by introducing a
repair template such as a plasmid or a small oligonucleotide, which spans the area with the break
and has matching sequences known as homology arms on either end; the desired mutation is
built into the middle of the template (Addgene, 2016). This process can be used to generate a
wide range of mutants, from single base pair changes to whole gene insertions.
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Figure 8: Homology-directed repair in a CRISPR mutant. Figure adapted from Addgene (2016).

In the past few years, CRISPR technology has become a revolutionary tool for the
scientific community, as it provides an efficient method of in vivo site-directed mutagenesis.
CRISPR was first adapted for use in C. elegans in 2013 by Friedland and colleagues. In order to
introduce mutations into the germline, the worm gonad is injected with a mix of Cas9 protein,
crRNAs, and a homology repair template, if this pathway is to be exploited. However, the
process of screening for progeny with the desired mutation can be labor intensive. In order to
mitigate this issue, a co-conversion strategy developed by the Seydoux lab can be used to
improve screening efficiency (Paix et al., 2015). Based on a protocol by Arribere et al. (2014),
Paix and colleagues created a cloning-free approach yielding high efficiency edits in C. elegans
(Figure 9). In order to streamline the screening process, they designed a CRISPR strategy that
creates two separate mutations in the genome: one at the locus of interest, and one on a separate
chromosome that produces an easily visible dominant phenotype at the dpy-10 gene. dpy-10
mutants display a characteristic roller behavior pattern which is easy to identify on sight. As
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such, progeny with at least one successful mutant can be identified without requiring laborintensive screening. These worms are far more likely to have received sufficient Cas9 protein,
crRNAs, and repair template copies for a successful mutagenesis at the site of interest, with a
success rate as high as 70% (Paix et al., 2015). Additionally, their protocol uses a direct-delivery
approach that requires no cloning, as the tracrRNA, crRNA, and repair oligonucleotide are all
synthesized chemically and injected together with Cas9.

Figure 9: Co-CRISPR strategy. (A) The marker mutation at dpy-10 is shown along with the mutation at the
locus of interest (Insertion of a fluorescent protein at the desired site). (B) Parent worms are injected and
screened for roller progeny; those with high proportions of roller worms are termed "jackpot broods." Figure
adapted from Paix et al., 2015.
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Present Work
The present study seeks to continue our work in identifying gene targets of DAF-19, with
a particular emphasis on determining isoform specificity. Five previously uncharacterized genes
identified by previous microarray experiments, T01B11.2, T07F10.1, del-4, srd-61, and decr-1.1
were tested for DAF-19 dependence in a variety of mutant backgrounds. Prasad Phirke and
others generated transcriptional fusions of each of these genes with GFP, and injected them into
worms that were either m86 or wild type for daf-19. We then generated isogenic strains for each
line by mating each injected strain with either the wild type or m86 strains, such that each
respective injection led to a pair of worm strains. GFP expression patterns of each target gene
were examined using confocal microscopy, with an emphasis on neuronal expression. If a
particular gene demonstrated differential expression patterns between wild type and m86
backgrounds, further strains were created that contained isoform-specific mutants. We obtained
a daf-19a/b mutant called tm5562 from the Mitani lab, which contained an 865 bp deletion of
exon 2 and a portion of the intron flanking sequence. Two further mutants were created by
Deborah Sugiaman at the Swoboda lab. Of these, one (of5) affects both DAF-19A and DAF19B via a 12 bp deletion with a +1 shifted ATG start codon, while the other (of6) contains a 53
bp deletion of exon 4 that affects only DAF-19B. These mutants were used to determine which
isoform was responsible for the differential expression observed in the m86 mutant (Figure 10).
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Figure 10: daf-19 isoforms. The locations of the m86, of5, tm5562, and of6 mutations are shown with black
arrows. Figure adapted from Wang et al. (2010).

In addition to characterizing the expression patterns of the five genes, we sought to
develop an isoform-specific mutant of daf-19 that would knock out DAF-19C only. As each
exon of DAF-19C is conserved in DAF-19A/B, this is a somewhat difficult proposition. We
designed a CRISPR mutagenesis strategy based on the previously described co-CRISPR
approach developed by Paix and colleagues (2015). We elected not to use dpy-10 as the coconversion marker mutation, as it is on the same chromosome as daf-19 and would therefore be
difficult to mate out of successful mutants. Instead, we chose to insert a copy of GFP into the
open reading frame of gtbp-1, a non-essential protein that is nevertheless expressed in most
tissues. To generate the CRISPR mutant, we designed two approaches intended to knock out
DAF-19C without affecting the function of the two long form isoforms. The first approach seeks
to replace the ATG start codon in exon 5 (the first exon of DAF-19C) with the codon for alanine
instead of methionine. We selected alanine for its small size and nonpolar character, which we
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expect to play a chemical role similar to that of methionine in the two long-form isoforms;
however, we hope that the lack of the initial start codon will be sufficient to stall translation of
DAF-19 C (Figure 11). In the event that this approach is unsuccessful, our second design
introduces a double frameshift mutation that creates a nonsense mutation in DAF-19C that is
subsequently corrected for in DAF-19A (Figure 11). In addition to our CRISPR design, we
optimized a purification protocol for Cas9 protein based on that provided by Paix and colleagues.
Ultimately, we hope that our new mutant will allow us to more thoroughly understand which
genes are activated and repressed by DAF-19A/B, in order to better understand their roles in the
synapse.
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Figure 11: CRISPR mutagenesis approaches. Figure A (mutagenesis #1) shows the location of a single
amino acid change from methionine to alanine at the start codon of exon five, which is expected to stall
translation of isoform C without significantly affecting the other isoforms. Figure B (mutagenesis #2) shows
the location of a double frameshift mutation that removes a single base from the beginning of exon five and
the addition of that same base at the end of exon three. This is expected to result in single frameshift
mutations that will knock out isoforms B and C while preserving the function of isoform A. Green checkmarks
note hypothesized functional isoforms, while red X’s show the presence of null alleles. Figure adapted from
Wang et al. 2010.
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MATERIALS AND METHODS
C. elegans strains and maintenance
All strains were maintained in a 15o or 20o incubator on 5 mm nematode growth medium
(NGM) agar plates, which were seeded with an E. coli OP50 lawn (Stiernagle, 1999) To
maintain each strain, hermaphroditic worms were transferred with a sterilized platinum pick to a
fresh agar plate approximately every five days, or by "chunking" a section of populated agar with
a sterilized spatula. Plates were wrapped with Parafilm strips to prevent drying or contamination
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Bischel
Katie Mueller

pT01B11.2::GFP; daf-19(tm5562)II; daf12(sa204)X
pT07F10.1::GFP; daf-19(tm5562)II; daf12(sa204)X
pT01B11.2::GFP; daf-19(of5)II; daf12(sa204)X
pT07F10.1::GFP; daf-19(of5)II; daf12(sa204)X
pT01B11.2::GFP; daf-19(of6)II; daf12(sa204)X
pT28B8.5::GFP; daf-19+; daf-12(sa204)X;
him-5(e1490)V
daf-19c::daf-19(m86); daf-12(sa204)X
pT07F10.1::GFP; daf-19a::daf-19(m86);
daf-12(sa204)X
pT07F10.1::GFP; daf-19c::daf-19(m86);
daf-12(sa204)X

LU495

Katie Mueller

OE3895

Katie Mueller

LU495

Katie Mueller

OE3895

Katie Mueller

OE3912

Katie Mueller

OE3492
LU495

Brian Piasecki
Katie Mueller

LU495

Katie Mueller
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LU

680

LU630

Katie Mueller

LU495

Katie Mueller

OE3895

Katie Mueller

LU630

Sophie Scholtz

OE3492
N/A

Gabi Senti
Swoboda Lab

N/A
N/A

Swoboda Lab
Swoboda Lab

N/A
N/A

Swoboda Lab
Swoboda Lab

N/A

Swoboda Lab

N/A

Swoboda Lab

N/A
N/A

Swoboda Lab
Swoboda Lab

5

pT01B11.2::GFP; gcy-32p::mCherry; daf12(sa204)X
pT07F10.1::GFP; gcy-32p::mCherry; daf12(sa204)X
pT01B11.2::GFP, daf-19c::daf-19(m86);
daf-12(sa204)X
pT01B11.2::GFP, daf-12(sa204)X, pha1(e2123)III; him-5(e1490); otls544 (cho1::SL2::mCherry pha-1+)
daf-19a::daf-19(m86); daf-12(sa204)X
daf-19(m86)II; daf-12(sa204)X; him5(e1490)V
pF43C11.3:GFP; daf-12(sa204)X
pT01B11.2::GFP; daf-19+; daf12(sa204)X
daf-19+; daf-12(sa204)X; him-5(e1490)V
pF43C11.3:GFP; daf-19(m86)II; daf12(sa204)X; him-5(e1490)V
pT01B11.2::GFP; daf-19(m86)II; daf12(sa204)X; him-5(e1490)V
pT28B8.5::GFP; daf-19(m86)II; daf12(sa204)X; him-5(e1490)V
pC01B4.5::GFP; daf-12(sa204)X
pC01B4.5::GFP; daf-19(m86)II; daf12(sa204)X; him-5(e1490)V
daf-19(of5)II

LU

682

LU

683

LU

685

OE
OE

3199
3492

OE
OE

3507
3705

OE
OE

3738
3869

OE

3895

OE

3912

OE
OE

4124
4133

OF

N/A

OF

6

daf-19(of6)II

N/A

AX

2419
dbEx8
64
13636

gcy-32p::mCherry

N/A

Deborah
Sugiaman
Deborah
Sugiaman
De Bono Lab

pha-1(e2123)III; him-5(e1490); otls544
(cho-1::SL2::mCherry pha-1+)

N/A

Hobert Lab

OH

Table 1: C. elegans strains used and analyzed.

Strain construction
All transgenic LU strains were constructed as isogenic pairs, meaning two strains with
different chromosomal mutations contain identical transgene arrays. All OE strains were
produced by separate microinjections in either daf-19 mutant or wild type backgrounds (Table
1). To produce crosses, 12 males from one parent strain and three L4 hermaphrodites from the
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second parent strain were picked to a fresh NGM plate and allowed to mate. Strains containing
the him-5(e1490)V allele produced high numbers of males to allow for easy mating; other male
populations were generated by heat shocking individual L4 hermaphrodites for 4-5 hours at 30o
C, allowing them to self-sex, and mating resulting male progeny with hermaphrodites of the
same strain.
To produce isogenic WT strains, hermaphrodites from transgenic daf-19(m86) strains
were mated with OE 3738 males. F1 progeny were dye filled, and transgenic dye filling
hermaphrodites were singly picked and allowed to self-sex. This step was repeated until 100%
of progeny were dye filling, indicating a homozygous daf-19+/+ allele. A similar method was
used to produce isogenic daf-19(tm5562)II, daf-19(of5), and daf-19(of6) strains, using males
with each respective mutation instead of OE 3738. Each of these mutants dye fill, so the same
assay was used to isolate progeny carrying the desired allele. This approach was also used to
create double transgenic rescue and marker strains. Several example crosses created to study the
gene T01B11.2 are shown in Table 2.
Strain
LU630

Crosses
OE3895 ⚥ x OE3738 ♂

LU641

OE3895 ⚥ x LU628 ♂

LU646

OE3895 ⚥ x OF5 ♂

LU653

OE3895 ⚥ x OF6 ♂

LU680

LU630 ⚥ x AX2419 ♂

LU683

OE3895 ⚥ x LU663 ♂

Genotype
pT01B11.2::GFP; daf-19+;
daf-12(sa204)X; him5(e1490)V
pT01B11.2::GFP; daf12(sa204)X; daf-19(tm5562)II
pT01B11.2::GFP; daf12(sa204)X; daf-19(of5)II
pT01B11.2::GFP; daf12(sa204)X; daf-19(of6)II
pT01B11.2::GFP; daf12(sa204)X; gcy-32p::mCherry
pT01B11.2::GFP, daf19c::daf-19(m86); daf12(sa204)X

Table 2: Example strain construction. Three L4 hermaphrodites and 12 adult males were mated for each
respective cross. Dye filling assays were used to isolate the desired phenotype, and were repeated until a
homozygous generation was produced.
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Dye filling assay
DiI staining, based on the protocol by Tong and Burglin (2010), stains amphid and
phasmid neurons in worms with functional cilia; thus, it can identify worms with either daf19+/+, daf-19(tm5562), daf-19(of5), or daf-19(of6) alleles. Strains containing the daf-19(m86)
allele show no staining of the amphid or phasmid neurons; as such, this is a useful tool for
determining daf-19 genotype in new strains or to identify worms containing an
extrachromosomal daf-19c rescue construct, which restores ciliary development. Finally, dye
filling can be used as an amphid and phasmid neuronal marker during confocal analysis,
providing a useful positional marker when attempting to discern GFP expression patterns in
transgenic worms. See Appendix A for details.
Confocal microscopy and anatomical analysis
Worm pads were created by melting 2% agarose and adding sodium azide to 10 mM.
Approximately 50 µl of solution was pipetted onto a slide and covered by a second slide that was
elevated slightly by two pieces of tape on adjacent slides (Figure 12). Worm pads were kept in a
humid chamber. Worms from an unstarved plate were then washed off an agar plate with 1 mL
of M9 buffer and allowed to settle in an Eppendorf tube. 3 µl of worms were transferred to a
worm pad with 3 µl of extra supernatant and the slide was tilted to evenly distribute the worms
before covering the pad with a cover slip. Transgenic expression patterns were analyzed using a
Leica SP5 confocal microscope and LAS AF SP5 software. Images were taken with a 40X lens
at zoom 2.0 for L4 and adult worms, zoom 3.0 for L3 worms, and zoom 4.0 for L1 and L2
worms (settings in Table 3). Images were compared to images and diagrams from
wormatlas.org in order to elucidate expression patterns.
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Type of Signal
GFP alone

GFP with
Mcherry/DiI/DS red

Settings
Argon laser on at ~20% power
HeNe 543 laser ~10%
HyD2 detector
495 – 595 nm for GFP
Argon laser on at ~20% power
HeNe 543 on at ~20%
594 laser at ~10%
488 laser ~10%
HyD2 detector
495 – 535 nm for GFP
HyD4 detector
650 – 790 nm for DiI or Mcherry

Table 3: Confocal settings for GFP and DiI/mCherry/DS red images. All images were collected using a Leica
SP5 confocal microscope and LAS AF SP5 software using the 40X lens.

Figure 12: Worm pad preparation. A drop of molten 2% agarose with 10 mM sodium azide was pipetted onto
one slide, then covered immediately with a second slide elevated by two adjacent pieces of tape.

CRISPR design and Cas9 purification
Two CRISPR mutagenesis designs were created based on the work of Paix and colleagues
(2015), which are detailed further in the results section of this thesis. Cas9 protein was purified
for use in CRISPR mutagenesis according to a protocol supplied by the Seydoux lab using the
nm2973 plasmid in E. coli, which they generously provided (Paix et al., 2015). This plasmid
contained a T7 viral promoter upstream of the Cas9 coding sequence, in addition to a
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carbenicillin resistance gene that could be used to select for plasmid-containing cells. The
bacteria were induced to produce an excess of Cas9 protein using IPTG, which was then purified
using Ni affinity and Sepharose chromatography and Pierce Cassette dialysis. Slight
modifications to their protocol are noted with asterisks in Appendix B.
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RESULTS
The present study seeks to identify putative DAF-19 target genes and determine
specifically which isoforms of DAF-19 control each target. Beth De Stasio and Prasad Phirke
identified genes that were differentially expressed in daf-19(WT) vs. daf-19(m86) backgrounds
via transcriptome analyses of 3-fold embryonic, L1 larval, and adult worms (Phirke et al., 2011).
From the lists of genes generated from L1 and adult worms, 30 genes were selected as likely
targets of regulation by DAF-19, and transcriptional fusions of the promoter region of each gene
with GFP were created and separately microinjected into the gonad of worms with a wild type
daf-19 gene. The present study seeks to characterize the expression patterns of five of these
genes: T01B11.2, T07F10.1, del-4, srd-61, and decr-1.1. For each transgene, isogenic daf19+/+ (WT) and daf-19(m86) worms were examined via confocal microscopy (Table 4). Those
that showed differential expression in these backgrounds were further analyzed by mating the
transgenes into worms containing one of three daf-19 mutations: tm5562, of5 and of6, all of
which affect the various isoforms of daf-19 differently (see Figure 4). These strains could then
be used to determine whether differential expression patterns were dependent on one or more
DAF-19 isoform. Furthermore, rescue experiments were done for several genes that were shown
to be DAF-19 dependent, by mating m86 worms with strains that contained cDNAs encoding
either the DAF-19A or DAF-19C isoforms. These reciprocal sets of experiments helped us to
determine how DAF-19 regulates gene expression.
Representative images from wormatlas.org were used to identify anatomical features in
which GFP was expressed, with a particular focus on identifying specific neurons. A minimum
of 20 worms of all ages were imaged and analyzed for each strain, in order to establish
representative phenotype profiles. The C. elegans nervous system has been extremely well
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mapped, and many functions of individual neurons have been elucidated. Thus, this study
sought to identify neuronal expression patterns as precisely as possible, in the hopes that the
known functions of these neurons would provide insights into potential new roles for daf-19,
particularly in synapse maintenance and other neuronal functions. In order to narrow down
potential neuronal expression patterns, the amphid neurons of WT worms were stained with a
lipophilic dye (DiI), thus providing anatomical landmarks for neuronal identification.
Additionally, several double transgenic lines were created by crossing the relevant strains with
worms containing a transgenic array that individually labeled a particular neuron, or set of
neurons, with the fluorescent protein mCherry. These were used to verify neuronal identity by
looking for co-localization of GFP and mCherry in neurons.

Gene name

Fold change
(adult)

T01B11.2
T07F10.1
del-4
srd-61
decr-1.1

1.16
0.43
1.3
1.48
2.6

Fold
change (L1
larvae)
0.62
1.0
0.4
2.2
0.41

Fold change (3fold embryo)
0.89
0.64
1.14
1.83
0.46

Presence of xbox binding
motif
Present
Not present
Present
Not present
Not present

Table 4: Relative transcription levels and sequence data for genes of interest. In most cases, genes were
selected for further analysis due to a fold change of >1.5 or < 0.5 in at least one array. Fold change is defined as the
relative transcription level of the gene in daf-19(m86) worms compared to wild type worms. Numbers shown are
averages of three microarray experiments per strain. Interestingly, many of these differentially expressed genes
lacked the characteristic x-box binding motif through which daf-19 is known to control gene expression.

Characterizations of gene expression patterns
T01B11.2 is activated by DAF-19
T01B11.2 was identified as a putative daf-19 target gene from Prasad Phirke’s
microarray analysis of L1 stage worms only. It is an ortholog of the human genes ETNPPL and
PHYKPL, both of which are phospho-lyases. Phospho-lyases are a subcategory of lyases,
enzymes that catalyze cleavage reactions (Lehninger et al., 2008); phospho-lyases act

Mueller, 27

specifically on phosphorus atoms. No clinical phenotypes are associated with either human
homolog. T01B11.2 is known to be involved in embryonic development, and RNAi screens
have shown that a lack of T01B11.2 is embryonic lethal; however, little else is known about its
function or mechanisms of control (Simmer et al., 2003). Based on protein domain information,
it is predicted to bind pyridoxal phosphate (PLP), and likely also has transaminase activity
(wormbase.org). Transaminases catalyze the transfer of amino groups from α-amino to α-keto
acids, an important step in catabolism. Thus, this gene may play a role in amino acid metabolism.
Additionally, it has been shown to interact with the SGT-1 protein, which plays a role in
embryonic and larval development, as well as reproductive processes (Li et al., 2004).
Transcriptome analysis of T01B11.2 by Elizabeth De Stasio and Prasad Phirke showed a
1.16 fold change in adult worms (up-regulation in daf-19 m86 worms), a 0.62 fold change in L1
larvae, and a 0.89 fold change in 3-fold embryos (down-regulation in daf-19 m86 worms). These
numbers were below the thresholds that were considered to be significantly differentially
expressed, as most genes were only analyzed further if they showed a fold change of >1.5 or
<0.5 in at least one array. However, T01B11.2 contains an x-box motif, which has been shown
to be a site of daf-19 mediated gene expression in various other genes. As such, it was
considered to be a reasonable candidate for further analysis, and a transcriptional fusion with
GFP was generated by our collaborator, Prasad Phirke.
Expression of T01B11.2::GFP in a daf-19(WT) genetic background
Two separately injected lines of daf-19(WT) worms containing the T01B11.2::GFP
transgene were analyzed for GFP expression via confocal microscopy (injections by Prasad
Phirke). One of these lines (OE3705) was injected directly into a daf-19 WT background, while
the other (LU630) is the isogenic partner strain to OE3895 (T01B11.2::GFP in a daf-19(m86)
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background) created as part of the present study. Anatomical features showing GFP expression
were identified via comparison with representative images from wormatlas.org (Figure 13).
Both strains show consistent expression of GFP in the intestine, hypodermis, body wall muscle,
and pharynx (Figure 14; Tables 5 and 6). Additionally, six muscle arms were visible in the
isthmus region of the pharynx. One to two pairs of neurons were visible in the dorsal region of
the isthmus, typically midway between the anterior and posterior pharyngeal bulbs.
Consistently, one of these pairs showed brighter GFP expression, and in some cases the second
pair of neurons was not visible. Their morphology showed a long dendrite projecting anteriorly
to the tip of the nose, with a second shorter dendrite extending ventrally across the isthmus.
Finally, inconsistent expression of GFP appeared in one tail neuron and several non-neuronal
cells, which were identified to be rectal glands surrounding the intestinal-rectal valve. Transgene
expression did not appear to be age dependent.

Figure 13: Representative images of anatomical structures identified in T01B11.2::GFP worms in a WT
background. (A) Muscle arms connecting to the nerve ring across the isthmus. (B) Body wall muscle cells, with
muscle arms connecting to the ventral nerve cord. (C) Pharyngeal muscle cells. (D – E) Rectal glands at the base of
the intestine. (F) Hypodermal cells of the head. (G) Intestinal cells. All images adapted from wormatlas.org.
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Figure 14: Expression of T01B11.2::GFP in a daf-19(WT) background. (A – B)
High GFP expression was observed in the hypodermis, body wall muscle,
intestine, and pharyngeal muscle, as well as 1-2 pairs of neurons in the isthmus.
(C – D) Intermittent expression was also visible in a single tail neuron and rectal
glands (not shown). Worms in this image and all images hereafter are oriented
according to the graphic shown at right, and all scale bars are 10 µm. Figures A
and B show an adult worm, while figures C and D show an L1 worm.
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Strain:
LU630
Age

Number of daf-19(WT) animals with observed expression of T01B11.2::GFP
N=

L1/L2
L3
L4
Adult

7
7
8
9

Total animals
with indicated
phenotype
(%)

31

Isthmus
neurons
7
7
8
9

Tail
neuron
3
3
1
1

Rectal
glands
6
3
0
0

Pharyngeal
muscle
7
7
8
9

Body wall
muscle
7
7
8
9

Intestine

Hypodermis

7
7
8
9

7
7
8
9

31
(100%)

8
(29%)

9
(29%)

31
(100%)

31
(100%)

31
(100%)

31
(100%)

Table 5: Localization of T01B11.2::GFP expression in a daf-19(WT) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed expression in 1-2 pairs of isthmus neurons, pharyngeal muscle, body wall muscle, intestine, and
hypodermal tissues, with intermittent GFP expression in one tail neuron and rectal gland cells.

Strain:
OE3705
Age

Number of daf-19 WT animals with observed expression of T01B11.2::GFP
N=

L1/L2
L3
L4
Adult

3
5
4
8

Total
animals with
indicated
phenotype
(%)

20

Isthmus
neurons
3
5
4
8

Tail
neuron
3
3
2
1

Rectal
glands
2
1
0
0

Pharyngeal
muscle
3
5
4
8

Body wall
muscle
3
5
4
6

Intestine

Hypodermis

3
5
4
6

3
5
4
8

20
(100%)

9
(45%)

3
(15%)

20
(100%)

18
(90%)

18
(90%)

20
(100%)

Table 6: Localization of T01B11.2::GFP expression in a separately injected daf-19(WT) background.
Hermaphrodite worms of indicated ages were observed with confocal microscopy, with expression appearing in the
indicated tissues. Worms consistently showed expression in 1-2 pairs of isthmus neurons, pharyngeal muscle, body
wall muscle, intestine, and hypodermal tissues, with intermittent GFP expression in one tail neuron and rectal gland
cells. Expression levels in this strain were comparable to those observed in LU630.

Expression of T01B11.2::GFP in a daf-19(m86) genetic background
A single line of daf-19(m86) worms containing the T01B11.2::GFP transgene was
analyzed for GFP expression via confocal microscopy (Strain name: OE3895). Injections were
completed by Prasad Phirke, and the strain is isogenic to LU630 (previously described).
Anatomical features showing expression were identified via comparison with representative
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images from wormatlas.org. Consistent GFP expression was observed in the intestine,
hypodermis, body wall muscle, pharynx, and muscle arms (Figure 15; Table 7). However, the
two pairs of neurons present in the isthmus were absent in 90% of worms imaged, indicating
differential expression. Inconsistent expression of GFP appeared in the rectal glands and one tail
neuron, which showed similar morphology to the neuron that was observed in the two WT
strains. Transgene expression did not appear to be age dependent.

Strain:
OE3895
Age

Number of daf-19(m86) animals with observed expression of T01B11.2::GFP
N=

L1/L2
L3
L4
Adult
Total
animals with
indicated
phenotype
(%)

Tail
neuron
5
2
1
2

Rectal
glands
12
5
2
3

Pharyngeal
muscle
13
6
4
7

Body wall
muscle
13
6
4
7

Intestine

Hypodermis

13
6
4
7

Isthmus
neurons
1
1
1
0

13
6
3
6

13
6
4
7

30

3 (10%)

10
(33%)

22
(73%)

30
(100%)

30 (100%)

28
(93%)

30
(100%)

Table 7: Localization of T01B11.2::GFP expression in a daf-19 (m86) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed expression in pharyngeal muscle, body wall muscle, intestine, and hypodermal tissues, with
intermittent GFP expression in one tail neuron and rectal gland cells. Notably, they lacked expression in isthmus
neurons, indicating differential expression. Expression levels in this strain were comparable to those observed in
LU630.
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Figure 15: Expression of T01B11.2::GFP in a daf-19(m86) background. (A –
B) High GFP expression was observed in the hypodermis, body wall muscle,
intestine, and pharyngeal muscle, but was absent from the neurons observed
in the isthmus in the isogenic WT strain (indicated by white circle). (C – D)
Intermittent expression was also visible in a single tail neuron and rectal
glands. All images show adult worms, and all scale bars are 10 µm.
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As DAF-19 dependency was established for T01B11.2, it was of interest to us to
specifically identify the neurons in which T01B11.2 was differentially expressed using WT
strains in which gene expression was more widespread. In order to narrow down candidate
neurons, worms from both transgenic WT strains were treated with DiI in order to stain the
amphid neurons ASK, ADL, ASI, AWB, ASH, and ASJ (Figure 16). Stained worms were then
imaged via confocal microscopy, and the isthmus neurons of interest were analyzed for colocalization of DiI with GFP (Figure 17). Co-localization was not observed; as such, all six
neurons were ruled out as potential candidates.

Figure 16: C. elegans amphid neurons. (A) Six amphid neurons dye fill when treated with DiI (ASK, ADL, ASK,
AWB, ASH, ASJ). Confocal image from http://www.wormatlas.org/EMmethods/DiIDiO.htm. (B) Schematic
adapted from wormatlas.org, with amphid neurons shown in red.
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Figure 17: Expression of T01B11.2::GFP in a daf-19(WT) background with
amphid neurons stained by DiI. The neuron of interest (A) did not colocalize with any dye-filling amphid neurons (shown in red, B – C). Images
show adult worms, and scale bars are 10 µm.

The amphid cell bodies were used as positional markers to identify other neurons in the
vicinity expressing GFP. While the precise positions of the GFP-expressing neurons varied
slightly, they generally appeared immediately anterior or posterior to the dorsal-most dye-filling
neurons. Based on their position and morphology, it was hypothesized that the brightest neuron
pair consisted of the right and left URX neurons, as this neuron appears in the mid-dorsal region
of the isthmus and has similar neuronal projections (Figure 18). Notably, it is one of few
neurons in the vicinity that does not connect to the nerve ring. As nerve ring expression was not
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definitively observed in either WT strain, this suggested URX to be a promising candidate as a
site of differential T01B11.2 expression.

Figure 18: Potential neuron of interest. The differentially expressed isthmus neuron present in T01B11.2::GFP
(WT) worms was hypothesized to be URX, shown in blue in the schematic to the left. All images adapted from
wormatlas.org.

In order to confirm the identity of URX, a strain of worms containing a fluorescent
mCherry marker (gcy-32p::mCherry) in the URX neuron was procured from the De Bono lab.
These worms were crossed with daf-19 WT worms (LU630) in order to produce double
transgenic worms containing both the URX marker and the T01B11.2::GFP transgene. Confocal
analysis revealed that the initial hypothesis was incorrect, as the mCherry marker did not colocalize with GFP (Figure 19).
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Figure 19. Expression of T01B11.2::GFP and gcy-32p::mCherry in a daf19+/+ background. (A – B) mCherry expression in the URX neuron did not
colocalize with GFP expression in the isthmus neuron of interest. Images
show adult worms, and scale bars are 10 µm.

Once URX was ruled out as a candidate for the neuron of interest, various other neurons
were considered as potential candidates. Based on a few images with decreased non-neuronal
expression, we determined that the neurons of interest did in fact connect to the nerve ring.
Additionally, we created a second double transgenic marker using a strain of worms that
expressed mCherry in the nuclei of all cholinergic neurons (strain by Sophie Scholtz). This was
used to confirm that the GFP-expressing neurons were not cholinergic, as they did not colocalize with mCherry (Figure 20). With these data, we were able to narrow down the possible
range of neurons to two pairs (ASG and AWA), based on their location and morphology (Figure
20). Both have cell bodies in the mid dorsal region of the isthmus, are quite close to the dyefilling amphid neurons, are non-cholinergic, and are posterior to URX, all features shared with
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the neurons of interest. As such, we currently hypothesize that T01B11.2 is activated in ASG
and AWA by DAF-19.

Figure 20: T01B11.2::GFP does not co-localize with mCherry expressed in cholinergic neurons. (A) A cho1::SL2::mCherry pha-1 marker was used to rule out the cholinergic neurons as potential sites for T01B11.2
expression, eliminating all but two cells as potential candidates. Image was taken by Sophie Scholtz, and shows an
adult worm, with scale bar showing 10 µm. (B) The isthmus neurons expressing T01B11.2::GFP in WT worms were
hypothesized to be ASG and AWA, shown in green. URX is shown in blue, and dye-filling amphid neurons are
shown in red. (C) Individual schematics of the hypothesized neurons. All images adapted from wormatlas.org.

Expression of T01B11.2::GFP in other daf-19 mutant worms
In addition to identifying specific neurons in which T01B11.2 was differentially
expressed in WT and m86 backgrounds, we were interested in elucidating how these expression
patterns were regulated. In order to determine whether particular DAF-19 isoforms are
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responsible for transcriptional regulation of T01B11.2, we produced three isogenic strains
containing the T01B11.2::GFP transgene in different genetic backgrounds for daf-19. Each of
these mutants affected DAF-19A, DAF-19B, or both, but not DAF-19C; as such, all three
displayed dye-filling phenotypes. In order to produce the isogenic strains, we mated daf19(m86) hermaphrodites with males that contained each respective mutation, and then selected
for dye-filling worms. The first of these was of5, a daf-19a/b null mutant produced by Debora
Sugiaman, which contained a 12 bp deletion with a +1 shifted ATG start codon that leaves only
DAF-19C functional (strain name: LU646). These worms showed an expression pattern that was
very similar to the two wild type strains that were analyzed, with consistent GFP expression in
the pharynx, body wall muscle, intestine, and hypodermis (Table 8). More importantly, 100% of
the worms analyzed expressed GFP in the isthmus neurons observed in the WT strains (Figure
21). This result indicates that T01B11.2 expression is not dependent on the presence of isoforms
A and/or B, as the transgene is expressed identically in WT and of5 genetic backgrounds. Thus,
these preliminary data suggest that DAF-19C regulates expression of T01B11.2.

Strain:
LU646
Age

Number of daf-19(of5) animals with observed expression of T01B11.2::GFP
N=

L1/L2
L3
L4
Adult

11
4
4
4

Isthmus
neurons
11
4
4
4

Tail
neuron
8
2
1
0

Rectal
glands
11
3
1
1

Pharyngeal
muscle
11
4
4
4

Body wall
muscle
11
4
4
4

Intestine

Hypodermis

11
4
4
4

11
4
4
4

Total
23
23
11
16
23
23
23
23
animals with
(100%)
(48%)
(76%)
(100%)
(100%)
(100%)
(100%)
indicated
phenotype
(%)
Table 8: Localization of T01B11.2::GFP expression in a daf-19(of5) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed GFP expression in 1-2 pairs of isthmus neurons, pharyngeal muscle, body wall muscle,
intestine, and hypodermal tissues, with intermittent fluorescence in one tail neuron and rectal gland cells.
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Figure 21: Expression of T01B11.2::GFP expression in a daf-19(of5) background.
(A – B) High GFP expression was observed in the hypodermis, body wall muscle,
intestine, and pharyngeal muscle, as well as in the isthmus neurons hypothesized
to be ASG and AWA in the isogenic WT strain (indicated by white circle). (C – D)
Intermittent expression was also visible in a single tail neuron and rectal glands.
All images show adult worms, and all scale bars are 10 µm.
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In order to further elucidate isoform-specific control mechanisms, we also generated a
strain of transgenic T01B11.2::GFP worms in a tm5562 background via the same process
described above (strain name: LU641). This mutant, obtained from the Mitani lab, contained a
large deletion in exon 2 which affected DAF-19A/B. Confocal analysis of this strain showed a
very similar expression pattern to the of5 mutant and both WT strains, with 95% of worms
expressing GFP in the isthmus neurons of interest (Figure 22). GFP expression in the pharynx,
body wall muscle, intestine, and hypodermis was also consistent with a WT phenotype (Table 9).
As with the of5 strain, these data suggest that T01B11.2 expression in these neurons is regulated
by DAF-19C.
Strain:
LU641
Age

Number of daf-19(tm5562) animals with observed expression of T01B11.2::GFP
N=

L1/L2
L3
L4
Adult

5
6
2
8

Total
animals with
indicated
phenotype
(%)

21

Isthmus
neurons
5
6
1
8

Tail
neuron
0
2
1
4

Rectal
glands
4
2
0
0

Pharyngeal
muscle
5
6
2
8

Body wall
muscle
5
6
2
8

Intestine

Hypodermis

5
6
2
8

5
6
2
8

20
(95%)

7
(33%)

6
(29%)

21
(100%)

21
(100%)

21
(100%)

21
(100%)

Table 9: Localization of T01B11.2::GFP expression in a daf-19(tm5562) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed GFP expression in 1-2 pairs of isthmus neurons, pharyngeal muscle, body wall muscle,
intestine, and hypodermal tissues, with intermittent fluorescence in one tail neuron and rectal gland cells.
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Figure 22: Expression of T01B11.2::GFP in a daf-19(tm5562) background. (A –
B) High GFP expression was observed in the hypodermis, body wall muscle,
intestine, and pharyngeal muscle, as well as in the isthmus neurons hypothesized
to be ASG and AWA in the isogenic WT strain (indicated by white circle). (C – D)
Intermittent expression was also visible in a single tail neuron and rectal glands.
All images show adult worms, and all scale bars are 10 µm.
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We generated an additional strain of transgenic T01B11.2::GFP worms in a daf-19(of6)
background via the same method described above. The of6 mutation, produced by our
collaborator Debora Sugiaman, consists of a 53 bp deletion in exon 4 that renders the protein
nonfunctional. However, since worms homozygous for the daf-19(of6) allele do dye fill and are
not dauer constitutive, this mutation appears not to affect DAF-19C. Unlike with the tm5562 and
of5 mutants that affect DAF-19A/B, this mutation negatively affects only DAF-19B, as exon 4 is
uniquely translated in this isoform. As such, DAF-19A and DAF-19C are left intact.
Interestingly, this strain showed extremely inconsistent expression across a variety of tissues,
including the neurons of interest (Tables 9 and 10). Of the worms imaged, 25% showed a
phenotype that resembled WT worms, featuring expression in the hypodermis, intestine, body
wall muscle, pharynx, and isthmus neurons (Figure 23 A – B). Another 50% expressed a
phenotype that resembled the m86 strain, which lacked the GFP expression in the isthmus
neurons of interest (Figure 23 C – D). Additionally, 25% of the worms imaged showed either
more or less GFP expression than either of the previously described tissues, in a variety of
phenotypes. This included worms with an absence of GFP in hypodermal and intestinal cells
which virtually always display fluorescence in other transgenic strains (Figure 23 E – F), as well
as worms with significantly increased neuronal overexpression in the isthmus in up to eight
neurons (Figure 23 G – H). Finally, tail expression patterns ranged from no GFP expression
(Figure 23 I – J) to neuronal GFP expression showing morphology that had previously not been
observed in any strain (Figure 23 K – L). Thus, no single definitive expression pattern for
T01B11.2::GFP (of6) worms could be established.
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Figure 23: Expression of T01B11.2::GFP in a daf-19(of6) background. (A – B) A
WT–like phenotype was observed in 25% of worms imaged, featuring GFP
expression in the hypodermis, body wall muscle, intestine, and pharyngeal muscle,
as well as in the isthmus neurons hypothesized to be ASG and AWA (indicated by
black circle). (C – D) An m86–like phenotype was observed in 50% of worms
imaged, with no GFP expression in the isthmus neurons of interest. (E – F) 25% of
worms showed novel phenotypes that had previously not been seen in any strain.
Panels E – F depict a worm that showed GFP expression in neuronal and pharyngeal tissue only. (G – H) An
additional novel phenotype showed considerable overexpression in neuronal tissue in the isthmus region. (I –
L) Tail expression patterns ranged from no neuronal expression (panels I – J) to increased neuronal
expression of GFP featuring novel dendrite morphology (panels K – L). Worm ages range from L1 to adult; all
scale bars are 10 µm.
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Strain: LU653
Age

N=

L1/L2
L3
L4
Adult

16
4
0
4

Number of daf-19(of6) animals with observed expression of T01B11.2::GFP
Isthmus
Tail
Rectal
Pharyngeal Body wall Intestine
Hypodermis
neurons
neuron
glands
muscle
muscle
8
5
10
16
14
14
15
2
1
1
3
3
3
3
0
0
0
4
4
4
4

Total animals
24
10
6
11
23
21
21
22
with indicated
(42%)
(25%)
(46%)
(96%)
(87%)
(87%)
(92%)
phenotype
(%)
Table 9: Localization of T01B11.2::GFP expression in a daf-19(of6) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
showed GFP expression in the isthmus neurons of interest 42% of the time.
Number of daf-19(of6) animals with each representative phenotype
Age
N=
WT
m86
Other phenotype
L1/L2
16
5
8
4
L3
4
1
1
2
L4
0
Adult
4
0
3
0
Total animals
24
6
12
6
with indicated
(25%)
(50%)
(25%)
phenotype
(%)
Table 10: Frequency of each representative phenotype in daf-19(of6)
worms. Worms showed highly variable expression patterns, including a
WT-like phenotype (25%), an m86 – like phenotype (50%), and several
novel phenotypes (25%).

While data from the tm5562 and of5 strains strongly suggested that T01B11.2 is regulated
by DAF-19C in isthmus neurons, the of6 result led us to question the certainty of that statement.
As we had no mutant that affected only daf-19c, we elected to do a rescue experiment using
cDNAs expressing only daf-19c. Complementary DNA (cDNA) is double-stranded DNA
synthesized from an mRNA template which can be used to reintroduce a gene transcript into an
animal for which that gene has previously been knocked out. Gabi Senti generated cDNAs for
daf-19c, which were incorporated into a plasmid that was then microinjected into a line of m86
worms (Senti & Swoboda, 2008). This plasmid is overexpressed; as such, worms containing this
transgene will have more DAF-19C expressed throughout the body than WT worms, and any

Mueller, 45

phenotypic data should be considered accordingly. The daf-19c rescue strain was crossed with
worms containing the T01B11.2 transgene in an m86 background in the same manner described
above (strain name = LU683). Worms were dye filled to select for the rescue transgene, as the
dye-filling phenotype depends on the presence of functional DAF-19C. These double transgenic
worms were then analyzed using confocal microscopy. Preliminary data have indicated that
these worms display a WT phenotype, with GFP expression clearly visible in the isthmus
neurons of interest, in addition to hypodermis, body wall muscle, intestine, and pharyngeal
muscle (Figure 24; Table 11). When taken in context with the data from tm5562 and of5
backgrounds, these data convincingly suggest that T01B11.2 is activated by DAF-19C.

Figure 24: T01B11.2::GFP expression after transformation rescue of the DAF-19C
isoform. (A – C) High GFP expression was observed in the hypodermis, body wall muscle,
intestine, and pharyngeal muscle. Addition of DAF-19C to daf-19 (m86) worms rescues
expression in the isthmus neurons of interest, hypothesized to be ASG and AWA. Dyefilled amphid neurons shown in red. All worms are adults, and all scale bars are 10 µm.
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Strain: LU683
Age

L1/L2
L3
L4
Adult

N
=
0
0
4
4

Number of daf-19c rescue animals with observed expression of T01B11.2::GFP
Isthmus
Tail
NonPharyngeal
Body
Intestine
Hypodermis
neurons neuron neuronal
muscle
wall
tail cells
muscle
3
0
0
4
4
4
4
4
0
0
4
4
4
4

Total animals
8
7
0
0
8
8
8
8
with indicated
(87%)
(0%)
(0%)
(100%)
(100%)
(100%)
(100%)
phenotype
(%)
Table 11: Localization of T01B11.2::GFP expression in a daf-19C::daf-19(m86) background. Hermaphrodite
worms of indicated ages were observed with confocal microscopy, with expression appearing in the indicated
tissues.

T07F10.1 expression may be partially regulated by DAF-19C
T07F10.1 was identified as a putative daf-19 target gene from Elizabeth De Stasio’s
microarray analysis of adult worms only, which showed a 0.43 fold change (down-regulation in
daf-19(m86) worms). It is an ortholog of the human genes ANPEP (alanyl membrane
aminopeptidase), ERAP1 (endoplasmic reticulum aminopeptidase 1) and other aminopeptidases
such as LNPEP (Shaye & Greenwald, 2011). Aminopeptidases are enzymes that catalyze
protein degradation by hydrolyzing amino-terminal residues from short peptides (Lehninger et
al., 2008). They are critically important for a wide variety of biological processes including
embryogenesis, antigen presentation, inflammation, and neuropeptide processing, and some
alleles of the human orthologs have been associated with pathologies such as hypertension
(Yamamoto et al., 2002). T07F10.1 localizes to the plasma membrane, and based on homology,
it is predicted to have metallopeptidase and zinc ion-binding activity (wormbase.org). Notably,
one of its human homologues (ANPEP) is thought to be involved in metabolizing regulatory
peptides in various cell types, including synaptic membranes in the CNS (omim.org). T07F10.1
is predicted to interact with tsp-7, a neuronally expressed protein that plays a role in
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morphogenesis, embryonic development, and mitotic spindle organization (Lee et al., 2008). No
information has been reported regarding its regulation, and interestingly, it lacks the
characteristic x-box motif through which daf-19 has been shown to regulate other genes.
Using a strain of transgenic worms produced by the Baillie lab, Alex Hurlburt reported
that T07F10.1::GFP is expressed in the pharynx, intestine, excretory system, and nervous system
in daf-19 WT worms (Hurlburt 2014; Table 12, Figure 25). Hurlburt was able to specifically
identify two head neurons, (URX and SABD) which showed GFP expression in 47% and 89% of
worms imaged, respectively. Additionally, he identified three pairs of tail neurons that expressed
GFP 100% of the time; these are PLM, PDA, and DVA/DVB. Hurlburt compared these
expression patterns with worms containing the T07F10.1::GFP transgene in an m86 background,
and found that URX and SABD only showed GFP expression 17% and 40% of time, respectively
(Table 13; Figure 26).
Hurlburt’s conclusions were verified by comparing data he collected with representative
anatomical images from wormatlas.org (Figures 27 and 28). Additionally, we were able to
definitively confirm his identification of the URX neuron as expression T07F10.1::GFP by
generating a double transgenic strain of worms containing a fluorescent mCherry marker (gcy32p::mCherry) in the URX neuron (generous gift of the De Bono lab). Confocal analysis of this
strain showed GFP in an isthmus neuron clearly co-localizing with mCherry, indicating that
Hurlburt’s initial identification was correct (Figure 29). Hurlburt was uncertain as to whether
this difference in expression frequency demonstrated true DAF-19 dependence; as such, we
elected to study the transgene's expression in various other mutant backgrounds of daf-19 in
order to better elucidate whether it regulates T07F10.1, and if so, by which isoforms.
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Strain: LU496
Age

N=

L1/L2
L3
L4
Adult

3
9
10
23

Total animals
with indicated
phenotype
(%)

45

Number of daf-19 WT animals with observed expression of T07F10.1::GFP
SABD
URX
Tail
Excretory
Vulval
Gonad
Intestine
neurons (#)
system
muscle
3
2
3 (2-3)
3
0
1
0
8
5
9 (3-4)
9
0
2
0
9
5
10 (2-5)
10
0
2
1
20
9
23 (2-5)
23
3
4
6
40
(89%)

21
(47%)

45
(100%)

45
(100%)

3
(7%)

9
(20%)

9
(20%)

Table 12: Localization of T07F10.1::GFP expression in a daf-19(WT) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed expression in the excretory system and three tail neurons, with intermittent GFP expression in
the URX and SABD neurons. Occasional expression was visualized in the gonad, intestine, and vulval muscle. All
data were collected by Alex Hurlburt in 2014.

Strain: LU495
Age

N=

L1/L2
L3
L4
Adult

3
7
14
23

Total animals
with indicated
phenotype
(%)

47

Number of daf-19 (m86) animals with observed expression of T07F10.1::GFP
SABD
URX
Tail
Excretory
Vulval
Gonad
Intestine
neurons (#)
system
muscle
0
0
3 (3-4)
3
0
0
0
2
1
7 (3-5)
7
0
1
0
10
5
14 (3-5)
13
0
1
0
7
2
23 (3-5)
23
3
4
0
19
(40%)

8
(17%)

47
(100%)

46
(98%)

3
(6%)

6
(13%)

0
(0%)

Table 13: Localization of T07F10.1::GFP expression in a daf-19(m86) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed expression in the excretory system and three tail neurons, with decreased GFP expression in the
URX and SABD neurons as compared to WT worms. Occasional expression was visualized in the gonad and vulval
muscle. All data were collected by Alex Hurlburt in 2014.
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Figure 25. Expression of T07F10.1::GFP in a daf-19(WT) background. (A –
D) Consistent GFP expression was observed in the pharyngeal muscle, excretory
canal and gland, and three pairs of tail neurons (PDA, PLM, DVA/DVB). 89% of
worms imaged expressed GFP in the SABD neuron, and 47% of worms expressed
GFP in the URX neuron. Occasional GFP expression was seen in the intestine,
gonad, and vulval muscle. All images were taken by Alex Hurlburt in 2014. All
worms shown are adults, and scale bars are 10 µm.
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Figure 26. Expression of T07F10.1::GFP in a daf-19(m86) background. (A –
D) Consistent GFP expression was observed in the pharyngeal muscle, excretory
canal and gland, and three pairs of tail neurons (PDA, PLM, DVA/DVB). GFP
was expressed less frequently in the SABD and URX neurons as compared to WT
worms (40% and 17% respectively). Occasional GFP expression was seen in the
gonad and vulval muscle. All images were taken by Alex Hurlburt in 2014. All
worms shown are adults, and scale bars are 10 µm.
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Figure 27: Representative images of non-neuronal anatomical structures identified in T07F10.1::GFP worms
in both WT and daf-19 (m86) backgrounds. (A – B) Excretory gland cells and excretory canals. (C) Intestinal
cells. (D) Pharyngeal muscle cells. All images adapted from wormatlas.org.

Figure 28: Schematics of neurons identified in T07F10.1::GFP worms. (A) Head neurons URX and SABD
shown in green. (B) Tail neurons PLM, PDA, and DVA/DVB show in green. (C) Schematics of all neurons. All
images adapted from wormatlas.org.
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Figure 29: Confirmation of T07F10.1::GFP expression in the URX neuron. (A – B) GFP expressed in the
isthmus neuron of interest co-localizes with mCherry in the URX neuron. Images depict an adult worm, and all
scale bars are 10 µm.

Expression of T07F10.1::GFP in a daf-19(of5) genetic background
In order to assess the possibility that regulation of T07F10.1 might be isoform-specific,
we generated an isogenic strain containing the T07F10.1::GFP transgene in an of5 background,
which lacks functional copies of DAF-19A/B. We created the strain by mating daf-19(m86)
hermaphrodites with daf-19(of5) males, and selecting for dye-filling worms in the F1 generation
(strain name: LU648). Confocal analysis revealed a GFP expression pattern similar to WT
worms, with consistent expression in the excretory system, pharyngeal muscle, and tail neurons,
for which the PDA and PLM pairs most frequently expressed GFP (Figure 30, Table 3).
Inconsistent GFP expression was also observed in the intestine and in several unidentified tail
cells. Notably, worms in this strain expressed GFP in the URX and SABD neurons 75% and
95% of the time, respectively. As these values are slightly higher than those previously reported
by Hurlburt for WT worms, this was sufficient to suggest a WT–like phenotype as compared to
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expression in the m86 strain. As this phenotype was observed in worms lacking functional DAF19A/B, these preliminary data would suggest that DAF-19C regulates expression of T07F10.1 in
either URX or SABD.

Strain:
LU648
Age

Number of daf-19(of5) animals with observed expression of T07F10.1::GFP
N=

SABD

URX

L1/L2
L3
L4
Adult

10
5
2
3

10
4
2
3

Total
animals
with
indicated
phenotype
(%)

20

19
(95%)

PDA

PLM

8
4
2
1

Excretory
system
10
5
2
3

Additional
tail cells
5
3
2
1

Intestine

Pharynx

10
5
2
2

DVA/
DVB
7
3
1
1

9
4
2
1

9
4
1
3

10
5
2
3

15
(75%)

20
(100%)

18
(90%)

19
(95%)

12
(60%)

11
(55%)

17
(85%)

20
(100%)

Table 14: Localization of T07F10.1::GFP expression in a daf-19(of5) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed expression in the excretory system and three tail neurons, with expression levels of GFP in the
URX and SABD neurons that were comparable to WT worms. Inconsistent expression was observed in the intestine
and several unidentified tail cells.
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Figure 30: Expression of T07F10.1::GFP in a daf-19(of5) background. (A –
D) Consistent GFP expression was observed in the pharyngeal muscle, excretory
canal and gland, and three pairs of tail neurons (PDA, PLM, DVA/DVB). GFP
was expressed in the SABD and URX neurons at a frequency slightly exceeding
that of WT worms (95% and 75% respectively). Occasional GFP expression was
seen in the gonad and vulval muscle, as well as in unidentified tail cells. Panels
A–B depict an L3 larval worm, and panels C–D depict an adult worm. All scale
bars are 10 µm.
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Expression of T07F10.1::GFP in a daf-19(tm5562) genetic background
In order to further assess whether the DAF-19A/B isoforms have any effect on
transcriptional regulation of T07F10.1, we generated an isogenic strain containing the
T07F10.1::GFP transgene in a tm5562 background. We created the strain by mating daf19(m86) hermaphrodites with daf-19(tm5562) males, and selecting for dye-filling worms in the
F1 generation (strain name: LU642). Confocal analysis revealed an expression pattern similar to
WT worms, with consistent expression in the excretory system, pharyngeal muscle, and tail
neurons, for which the PDA and PLM pairs most frequently expressed GFP (Figure 31, Table
15). Inconsistent GFP expression was also observed in the intestine and in several unidentified
tail cells. Notably, worms of this strain expressed GFP in the URX and SABD neurons 65% and
91% of the time, respectively. As these values are slightly higher than those previously reported
by Hurlburt for WT worms, this was sufficient to suggest a WT phenotype. Thus, it does not
appear that DAF-19A is required to activate T07F10.1. Overall, these preliminary data suggest
that DAF-19C may regulate expression of T07F10.1.

Strain:
LU642
Age

Number of daf-19(tm5562) animals with observed expression of T07F10.1::GFP
N=

SABD

URX

L1/L2
L3
L4
Adult

14
3
3
3

14
3
1
3

11
1
1
2

Excretory
system
14
3
3
3

PDA

PLM

11
3
2
3

13
2
3
3

DVA/
DVB
10
2
0
0

Additional
tail cells
6
0
1
1

Intestine

Pharynx

11
1
0
3

14
3
3
3

Total
23
21
15
23
19
21
12
8
15
23
animals
(91%) (65%)
(100%)
(83%) (91%) (52%)
(35%)
(65%)
(100%)
with
indicated
phenotype
(%)
Table 15: Localization of T07F10.1::GFP expression in a daf-19(tm5562) background. Hermaphrodite worms
of indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues.
Worms consistently showed fluorescence in the excretory system and three tail neurons. Expression levels of GFP in
the URX and SABD neurons were comparable to WT worms. Inconsistent expression was observed in the intestine
and several unidentified tail cells.
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Figure 31: Expression of T07F10.1::GFP in a daf-19(tm5562) background. (A – E)
Consistent GFP expression was observed in the pharyngeal muscle, excretory canal and
gland, and three pairs of tail neurons (PDA, PLM, DVA/DVB). GFP was expressed in the
SABD and URX neurons at a frequency slightly exceeding that of WT worms (91% and
65% respectively). Occasional GFP expression was seen in the gonad and vulval muscle,
as well as in unidentified tail cells. Panels D – E show dye-filling phasmid neurons in red
as a positional marker. All worms shown are adults, and all scale bars are 10 µm.
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T07F10.1::GFP expression in a daf-19(m86) background is rescued by daf-19c expression
While preliminary data suggested that T07F10.1 is regulated by DAF-19C, we were
uncertain as to whether the changes in GFP fluorescence identified between WT and m86 strains
constituted true differential expression. As we lacked a mutant specific to daf-19c, we elected to
perform transformation rescues using cDNAs for daf-19a and daf-19c. Gabi Senti generated a
daf-19c rescue strain by injecting an expression plasmid containing cDNAs for daf-19c into m86
worms. An isogenic strain of double transgenic worms was then created by crossing worms
from this line with worms containing the T07F10.1::GFP transgene in an m86 background (strain
name: LU676). This plasmid is overexpressed; thus, worms of this strain have an abundance of
DAF-19C, but no other isoforms of the protein. Consistent GFP expression was observed in the
pharynx, tail neurons, and excretory system, with occasional expression in unidentified tail cells.
The two neurons of interest, URX and SABD, each expressed GFP in 94% of worms imaged
(Table 16; Figure 32). These expression frequencies were significantly higher than those
reported by Hurlburt in either WT or m86 worms. As DAF-19C is overexpressed in these
worms, this result is consistent with WT-like phenotypes observed in the of5 and tm5562 strains,
which supports the hypothesis that T07F10.1 is regulated by DAF-19C.
Strain:
LU676
Age

Number of daf-19c rescue animals with observed expression of T07F10.1::GFP
N=

SABD

URX

L1/L2
L3
L4
Adult

20
6
1
5

20
6
1
3

19
5
1
5

Excretory
system
19
6
1
4

PDA

PLM

DVA/DVB

17
6
1
4

20
6
1
5

18
6
1
5

Additional
tail cells
1
1
0
1

Pharynx
20
6
1
5

Total
32
30
30
30
28
32
30
3
32
animals
(94%)
(94%)
(94%)
(87%)
(100%)
(94%)
(9%)
(100%)
with
phenotype
Table 16: Localization of T07F10.1::GFP expression in a daf-19C::daf- 19(m86) background. Hermaphrodite
worms of indicated ages were observed with confocal microscopy, with expression appearing in the indicated
tissues.
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Figure 32: T07F10.1::GFP expression after transformation rescue of the DAF-19C isoform. (A – B) URX and
SABD were expressed in 94% of worms imaged. Consistent GFP expression was observed in pharyngeal muscle
and excretory tissues, with intermittent expression in unidentified tail cells. All worms pictured are adults, and all
scale bars are 10 µm.
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As a final experiment, we performed another transformation rescue experiment using daf19a. As described previously, Gabi Senti generated a transgenic rescue line by microinjecting
m86 worms with a plasmid incorporating cDNAs for daf-19a. We then created a double
transgenic rescue line using the method detailed above, which overexpressed DAF-19A only
(strain name: LU675); we then expressed T07F10.1::GFP expression using confocal microscopy.
Consistent GFP expression was observed in the pharynx and tail neurons, with frequent
expression in the excretory system, and occasional expression in unidentified tail cells. The two
neurons of interest, URX and SABD, expressed GFP in 68% and 72% of worms imaged,
respectively (Table 17; Figure 33). These expression frequencies were significantly higher than
those reported by Hurlburt in m86 worms (see Table 13), but lower than those reported in WT,
daf-19c rescue, tm5562, and of5 worms. These results provide weak evidence that T07F10.1
may be regulated by DAF-19C; however, given the variability of the expression patterns between
these various strains, these data are insufficient to conclusively prove that T07F10.1 is solely
regulated by DAF-19.

Strain:
LU675
Age
L1/L2
L3
L4
Adult
Total
animals
with
indicated
phenotype
(%)

Number of daf-19a rescue animals with observed expression of T07F10.1::GFP
N
=
7
5
6
7

SABD

URX

PDA

PLM

DVA/DVB

7
4
5
1

Excretory
system
6
4
5
6

7
5
4
2

25

18
(72%)

Pharynx

6
5
6
6

Additional
tail cells
3
0
0
0

7
5
6
7

7
5
6
6

17
(68%)

21
(84%)

25
(100%)

24
(96%)

23
92%

3
(12%)

25
(100%)

7
5
6
7

Table 17: Localization of T07F10.1::GFP expression in a daf-19A::daf- 19(m86) background. Hermaphrodite
worms of indicated ages were observed with confocal microscopy, with expression appearing in the indicated
tissues.
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Figure 33: T07F10.1::GFP expression after transformation rescue of the DAF-19A isoform. (A – D) URX and
SABD were expressed in 68% and 72% of worms imaged, respectively. Consistent GFP expression was observed
in pharyngeal muscle and excretory tissues, with intermittent expression in unidentified tail cells. All worms
pictured are adults, and all scale bars are 10 µm.
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srd-61 expression is independent of DAF-19
srd-61 was identified as a putative DAF-19 target gene from Prasad Phirke's
microarray analysis of L1 larvae and 3-fold stage embryos, which showed a 2.2 and 1.8 fold
change respectively (up-regulation in daf-19(m86) worms). Elizabeth De Stasio's
microarray analysis of adult worms also showed a 1.48 fold change. Combined, these three
microarrays suggested that srd-61 expression is likely to be regulated by DAF-19, although
srd-61 lacks the characteristic x-box motif through which DAF-19 is known to regulate
other genes. No data have been reported regarding the regulation of srd-61 or its
interaction with any other proteins; however, srd-61 expression has been previously
identified in several C. elegans neurons, including ASH, ASI, PHA, and PHB (Colosimo et al.,
2004).
srd-61 is a seven transmembrane G-protein-coupled receptor (7TM GPCR). This
gene family consists of proteins that span the plasma membrane via a 7TM domain. The
7TM domain is comprised of seven helices embedded within the membrane that attach to
an extracellular receptor, which can bind particular ligands. Upon binding, the 7TM
domain will undergo a conformational change, which activates a cytosolic GTP-binding
protein (G-protein) specific to the particular receptor. The inactivated form of this Gprotein carries a GDP molecule in one of its domains, and upon receiving a signal from the
activated 7TM domain, it exchanges this GDP molecule for GTP. This leads to a signaling
cascade that may affect various cellular processes, including gene transcription (Lehninger
et al., 2008). srd-61 has no known human homologs, and thus is associated with no specific
disease states. However, humans have around 750 different GPCR genes, many of which
have been associated with endocrine diseases (Vassart & Costagliola 2011). srd-61 is a
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member of the serpentine receptor class d (Srd) family, which contains various genes that
regulate chemoreception (Robertson & Thomas, 2006). Chemoreception, or the ability of
an organism to sense its environment through the presence of small molecules, is a critical
element of olfaction. As DAF-19 has previously been shown to regulate gene expression in
ciliated sensory neurons (which are responsible for olfaction), we hypothesized that DAF19 might regulate srd-61 in these tissues.
Expression of srd-61::GFP in a daf-19(WT) genetic background
Prasad Phirke generated a transcriptional fusion of the srd-61 promoter region with GFP,
and injected this separately into WT and m86 worms. Confocal analysis of the WT strain
(OE4124) showed consistent expression of GFP in 1-2 pairs of tail neurons as well as in a single
pair of isthmus neurons that connected to the nerve ring. The latter neurons only expressed GFP
in 51% of worms imaged (Table 18, Figure 34). A dye-filling assay was performed to determine
the identity of these neurons. The isthmus neuron was clearly identified to be ASH, as GFP
expression co-localized with red DiI in this pair of neurons. Additionally, the two pairs of tail
neurons were identified to be PHA and PHB, the two dye-filling phasmid neurons (Figure 35).

Strain: OE4124
Age
L1/L2
L3
L4
Adult

Number of daf-19(WT) animals with observed expression
of srd-61::GFP
N=
ASH neurons
PHA/PHB neurons
39
27
39
4
2
4
8
3
8
23
6
23

Total animals with
74
38
74
indicated phenotype (%)
(51%)
(100%)
Table 18: Localization of srd-61::GFP expression in a daf-19(WT) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed expression in the PHA/PHB neurons, and intermittent expression in the ASH neurons (51% of
worms imaged).
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Figure 34: Expression of srd-61::GFP in a daf-19(WT) background. (A)
Consistent GFP expression was observed in a single pair of isthmus neurons,
which fluoresced in 51% of worms imaged. (B – C) A dye-filling assay was used
to identify this pair of neurons as ASH. (D) Consistent GFP expression was
observed in 1-2 tail neurons. (E – F) A dye-filling assay was used to identify
these neurons to be PHA/PHB. Panels A – C show an L2 stage worm, and panels
D – E show an adult. All scale bars are 10 µm.

Figure 35: Schematics of neurons identified in srd-61::GFP worms. (A) Schematic of the amphid neuron ASH.
(B) Schematic of the phasmid neurons PHA and PHB. All images adapted from wormatlas.org.
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Expression of srd-61::GFP in a daf-19(m86) genetic background and an isogenic WT strain
A single line of daf-19(m86) worms containing the srd-61::GFP transgene was analyzed
for GFP expression via confocal microscopy (OE4133). These worms demonstrated expression
in the same head and tail neurons observed in the WT strain; however, the isthmus neuron pair
fluoresced in 100% of worms imaged (Table 19, Figure 36). Given this variability in expression
frequency, the preliminary data suggested that srd-61 might be regulated by DAF-19 in the ASH
neurons. To confirm this, the isogenic strain for OE4133 was created by mating daf-19(m86)
worms containing the srd-61::GFP transgene to WT worms, and selecting for dye-filling
progeny. This resulted in a new strain (LU627), which was similarly analyzed via confocal
microscopy. This strain showed srd-61::GFP expression in the ASH and PHA/PHB neurons in
all worms imaged; thus, the phenotype was identical to its isogenic m86 strain (Table 20, Figure
37). These data indicate that srd-61 is not regulated by DAF-19.
Strain: OE4133
Age
L1/L2
L3
L4
Adult

Number of daf-19 (m86) animals with observed expression of srd-61
N=
ASH neuron
PHA/PHB neurons
11
11
11
3
3
3
10
10
10
7
7
7

Total animals with
31
31
31
indicated phenotype (%)
(100%)
(100%)
Table 19: Localization of srd-61::GFP expression in a daf-19(m86) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed expression in the ASH neurons and the PHA/PHB neurons.
Strain: LU627
Age
L1/L2
L3
L4
Adult

Number of daf-19 WT animals with observed expression of srd-61
N=
ASH neuron
PHA/PHB neurons
27
27
27
8
8
8
5
5
5
10
10
10

Total animals with
50
50
50
indicated phenotype (%)
(100%)
(100%)
Table 20: Localization of srd-61::GFP expression in a daf-19(m86) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
consistently showed expression in the ASH neurons and the PHA/PHB neurons.
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Figure 36: Expression of srd-61::GFP in a daf-19(m86) background. (A – B)
Consistent GFP expression was observed in the ASH neuron pair, which
fluoresced in 100% of worms imaged. (B – C) Consistent GFP expression was
observed in the PHA/PHB neurons. It should be noted that this strain is not
isogenic to OE4124. Panels A – B show an adult worm, and panels C – D show
an L3 stage worm. All scale bars are 10 µm.
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Figure 37: Expression of srd-61::GFP in a second line of daf-19(WT) worms.
(A – B) Consistent GFP expression was observed in the ASH neuron pair, which
fluoresced in 100% of worms imaged. (B – C) Consistent GFP expression was
observed in the PHA/PHB neurons. It should be noted that this strain is isogenic
to OE4133. All worms shown are adults, and all scale bars are 10 µm.
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del-4 expression appears age-dependent in the absence of DAF-19
del-4 was identified as a putative daf-19 target gene from Prasad Phirke's microarray
analysis of L1 larval worms. del-4 is classified as a degenerin-like gene, a group of proteins
which participate in neuronal mechanotransduction, or the process by which neurons convert a
mechanical stimulus to electrical activity (Kellenberger & Schild, 2002). The ‘del’ gene
designation indicates that defects in these genes result in degeneration of sensory neurons
(Kellenberger & Schild, 2002). del-4 is an ortholog of various members of the human nonvoltage gated sodium channel family, including SCNN1B, SCNN1D, SCNN1A, and SCNN1G
(NCBI.gov). These four genes code for epithelial sodium channels, which are transmembrane
proteins that selectively allow sodium ions to permeate the plasma membrane. Clinical
phenotypes associated with defects in these genes include Liddle's syndrome, a disease
characterized by hypertension resulting from abnormally high levels of sodium ions in the
kidneys (Kellenberger & Schild, 2002). Additionally, del-4 is thought to be a potential model for
bronchiectasis, a condition characterized by chronic bronchial inflammation (Azad et al., 2009).
Using a whole-genome interactome approach, Zhong and Sternberg predicted that del-4 interacts
with F58G6.7, a copper ion transporter, and T16G1.5, a protein of unknown function with
kinase-like domains (2006).
Transcriptome analysis of del-4 by Elizabeth De Stasio and Prasad Phirke showed a 0.4
fold change in L1 larvae (down-regulation in daf-19(m86) worms) a 1.3 fold change in adult
worms, and a 1.14 fold change in 3-fold embryos (no significant expression in daf-19(m86)
worms). del-4 contains the characteristic x-box motif which has been shown to be a site of daf19 mediated gene expression. As such, it was considered to be a promising candidate for further
analysis. Prasad Phirke found del-4 expression in four neurons using fluorescence microscopy,
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which he believed to be ASE, AIN, PHA, and PQR (unpublished). Additionally, Echtberger and
colleagues identified del-4 expression in the ASE gustatory neuron, which is necessary for taste
reception (2007).
Expression of del-4::GFP in a daf-19(WT) genetic background
Prasad Phirke generated a transcriptional fusion of the del-4 promoter region with GFP,
and injected this into daf-19(m86) worms (OE3912). Hermaphrodites of this strain were mated
with male worms with a daf-19(WT) genetic background to produce the isogenic WT strain
(LU655). Confocal analysis of this strain showed mosaic expression in 0–8 head neurons and 1–
3 tail neurons (Figure 38, Table 21). The most commonly observed neurons in the head included
a bright pair of mid-isthmus neurons with a long dendrite reaching the tip of the nose, and a pair
of neurons near the base of the nerve ring. Other neurons that appeared less frequently included
an additional cell body located underneath the posterior bulb, and several fainter cell bodies in
the mid-isthmus region that occasionally extended long dendrites toward the nose.
A dye-filling assay was performed to identify as many of these neurons as possible.
While no GFP-expressing neurons were also found to dye fill, the dye-filling amphid neurons,
these served as useful positional markers for neuronal identification. Based on its location and
data from Prasad Phirke and Echtberger et al. (2007), the bright mid-isthmus neuron appearing in
60% of worms imaged is hypothesized to be ASE (Figure 39). The neurons appearing at the
base of the isthmus were much more difficult to narrow down. Current hypotheses include the
RMDD, AIB, RMF, RMH, and AIA neuron pairs. The tail neurons could not be definitively
identified without some kind of co-localizing marker; however the most likely candidates are
PQR, PHA and PHB, of which the former two neurons were hypothesized by Prasad Phirke
(Figure 40).
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Figure 38: Expression of del-4::GFP in a daf-19(WT) background. (A – C) Mosaic GFP
expression was observed in up to 8 head neurons, with the most frequent expression occurring
in the two indicated cells. A dye-filling assay was used to identify these neurons, which are
hypothesized to be ASE and a second pair at the base of the nerve ring, possibly RMDD, AIB,
RMF, RMH, or AIA. ASE fluoresced in 60% of worms imaged, and the ventrally located
neuron fluoresced in 88% of worms imaged. (D – E) Up to 3 tail neurons located just posterior
to the anus fluoresced; these are thought to be PQR, and either PHA or PHB. Panels A – C
depict an adult male worm, and panels D – E depict an L3 larval worm. All scale bars are 10 µm.

Mueller, 70

Strain:
LU655
Age
L1/L2
L3
L4
Adult
Total
animals with
indicated
phenotype
(%)

Number of daf-19 WT animals with observed expression of del-4::GFP
N=
9
2
0
14

Head neurons (#)
9 (1-8)
2 (2-4)
14 (2-4)

Tail neurons (#)
5 (1-2)
1 (2)
6 (1-3)

Intestine
6
2
7

25

25 (100%)

12 (48%)

15 (60%)

Table 21: Localization of del-4::GFP expression in a daf-19(WT) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
showed mosaic expression of GFP in up to 8 head neurons and up to 3 tail neurons, as well as intermittent intestinal
expression.

Figure 39: Schematics of neurons identified in del-4::GFP worms. (A) Schematic of the amphid neuron ASE.
(B) Confocal image of the amphid neuron ASE. (C) Schematic of the hypothesized head neurons which may
express del-4::GFP. (D) Schematics of five possible neurons that may be expressing GFP near the base of the nerve
ring. All images adapted from wormatlas.org
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Figure 40: Schematics of neurons identified in del-4::GFP worms. (A) Confocal image showing the PHA and
PHB neuron. (B) Confocal image showing the PQR neuron. (C – D) Schematics of the hypothesized tail neurons
which may be expressing del-4::GFP. All images adapted from wormatlas.org.

Expression of del-4::GFP in a daf-19(m86) genetic background
An isogenic strain of del-4::GFP worms in a daf-19(m86) genetic background was
analyzed for GFP expression via confocal microscopy (OE3912). These worms showed a
similarly mosaic pattern of del-4::GFP expression in 1–6 isthmus neurons and 0–4 tail neurons
(Figure 41; Table 22). As with the WT strain, the neurons which most frequently expressed GFP
were the mid isthmus neuron pair predicted to be ASE, and the second pair immediately
posterior to the base of the nerve ring (likely to be RMDD, AIB, RMF, RMH, or AIA).
Interestingly, these worms showed age-dependent expression, as L1 and L2 larvae expressed
GFP in an average of 3.58 neurons, while adults expressed GFP in an average of 1.67 neurons
(Figure 42). This age-dependent expression was not visible in WT worms. In spite of the
variability in age-related expression between the WT and m86 strains, the overall similarity in
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phenotypes suggests that del-4 is not regulated by daf-19, and further experiments will be
required to determine whether the age-dependent expression in m86 worms is significant to our
study.

Figure 41: Expression of del-4::GFP in a daf-19(m86) background. (A – B) Mosaic GFP
expression was observed in up to six head neurons, with the most frequent expression occurring in
the two indicated cells, hypothesized to be ASE and a second unidentifiable pair. ASE fluoresced
in 65% of worms imaged, and the ventrally located neuron fluoresced in 95% of worms imaged.
(C – D) Up to four tail neurons located just posterior to the anus fluoresced; these are thought to
include PQR, and either PHA or PHB. All images show L2 worms, and all scale bars are 10 µm.
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Strain:
OE 3912
Age
L1/L2
L3
L4
Adult
Total
animals with
indicated
phenotype
(%)

Number of daf-19(m86) animals with observed expression of del-4::GFP
N=
17
10
3
7

Head neurons (#)
17 (2-6)
10 (1-4)
3 (1-3)
6 (1-2)

Tail neurons (#)
9 (1-3)
4 (1-4)
0
3 (1-3)

Intestine
14
8
2
4

37

36 (97%)

16 (43%)

28 (76%)

Average Number of Isthmus Neurons

Table 22: Localization of del-4::GFP expression in a daf-19(m86) background. Hermaphrodite worms of
indicated ages were observed with confocal microscopy, with expression appearing in the indicated tissues. Worms
showed mosaic expression of GFP in up to six head neurons and up to four tail neurons, as well as intermittent
intestinal expression.

6

5

4

3

WT
m86

2

1

0
L1/L2

L3

L4

adult

Age
Figure 42: Average isthmus neuron expression of del-4::GFP is age-dependent a daf-19(m86) background.
m86 worms showed GFP expression in progressively fewer neurons as they aged, with a statistically significant
difference between L1/L2 larvae and adult worms. No statistically significant difference was seen in WT worms.
Error bars show 1 standard deviation.
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decr-1.1 expression was not observed in daf-19(WT) or daf-19(m86) worms
decr-1.1 is a member of the DiEnoyl-CoA reductase family of mitochondrial genes.
While little is known about decr-1.1, other C. elegans genes in this family are orthologous to the
human DECR1 protein, which plays a role in metabolizing fatty enoyl-CoA esters (Helander et
al., 1997). decr-1.1 has no known interactions with other proteins, and no data have been
reported regarding its regulation. It was identified as a putative DAF-19 target gene by Prasad
Phirke's microarray analysis of L1 larvae and 3-fold stage embryos and Elizabeth De Stasio's
microarray analysis of adult worms, with fold changes of 0.41, 0.46, and 2.6, respectively. This
indicates that decr-1.1 is up-regulated in adult worms and down-regulated in embryonic and
larval worms with a daf-19(m86) genetic background. While decr-1.1 lacks the characteristic xbox motif through which DAF-19 is known to regulate other genes, the degree of differential
expression in WT vs. m86 worms suggests that it is a probable candidate for DAF-19
dependency.
A transcriptional fusion of the decr-1.1 promoter region with GFP was generated and
injected separately into daf-19(WT) and daf-19(m86) worms (Prasad Phirke). Both strains were
analyzed for GFP expression via confocal microscopy. Surprisingly, neither strain showed
visible GFP expression in any tissues (Table 23). As such, it was impossible to determine
whether decr-1.1 is regulated by DAF-19, as no phenotype could be established. Each strain
expressed an mCherry transgenic marker that was also incorporated into the plasmid, so the
problem does not appear to lie with faulty microinjections. Rather, the decr-1.1 promoter region
may not be fully contained by the transcriptional fusion. Additionally, it is possible that levels of
decr-1.1 expression are simply too low to be visualized with GFP in either genetic background.
Two additional lines of worms have been injected with the decr-1.1::GFP transgene and will be
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analyzed for GFP expression. If these fail to show fluorescence, it may be necessary to create a
new transcriptional fusion incorporating a larger portion of the sequence upstream of decr-1.1, in
order to better capture the promoter region.

Genetic Background
Age

N=

daf-19(m86)
Number of worms
showing GFP expression
0
0
0
0
0%

N=

daf-19(WT)
Number of worms
showing GFP expression
0
0
0
0
0%

L1/L2
14
12
L3
15
9
L4
13
13
Adult
8
16
Total animals with
50
50
indicated phenotype (%)
Table 23: Transgenic expression of decr-1.1::GFP in daf-19(WT) and daf-19(m86) genetic backgrounds.
GFP was not observed in worms expressing the decr-1.1::GFP transgene in either WT or m86 genetic
backgrounds for daf-19.

CRISPR Design
Of the five genes studied, at least one, T01B11.2, appears very likely to be regulated by
DAF-19C, and T07F10.1 may be as well. More importantly, none of the genes studied appear to
be regulated by DAF-19A/B. In order to confirm that DAF-19C is responsible for the expression
patterns observed, it is important to be able to show not only that worms containing functional
DAF-19C in a daf-19(m86) background show a WT phenotype, but also that worms lacking only
this isoform show an m86 phenotype. While rescue experiments using daf-19a cDNAs can
mimic this genetic background, there are confounding factors that could affect the accuracy or
viability of these experiments. Firstly, the amount of DAF-19 expressed in a rescue experiment
depends on the number of copies of the transgene that are contained in each worm, which will
result in different levels of expression than in worms expressing chromosomal daf-19. Secondly,
daf-19a rescue experiments were not possible in T01B11.2::GFP transgenic worms, as they
express GFP too brightly to see the fluorescent marker that identifies daf-19A::daf-19(m86)
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worms. These worms are dye-filling defective, so we could not use a dye-filling assay to
identify them as we did with daf-19C cDNA in daf-19(m86) worms. As T01B11.2 shows the
strongest evidence for DAF-19C dependent expression of all the genes studied, we wished to
find a new way to test transgenic expression in a daf-19c -/- background. As such, we designed
two CRISPR mutagenesis strategies intended to knock out DAF-19C while leaving DAF-19A/B
intact.
It should be noted that the precise sequence of the DAF-19C protein is not known, as
conflicting evidence suggests that this isoform begins either in exon 4 or in exon 5 (Figure 43).
daf-19c was originally thought to begin in exon 4, based on RNase protection assays completed
by Gabi Senti in 2008. However, two separate transcripts for a potential short form daf-19c
isoform are reported on wormbase.org, one of which begins with exon 4 and the other with exon
5. Additionally, data from the daf-19(of6) mutant, which affects exon 4, suggests that this exon
is not included in DAF-19C and that translation begins with the ATG at the start of exon 5. The
of6 mutant, generated by Debora Sugiaman, has a WT dye-filling phenotype. This suggests that
of6 worms express functional DAF-19C, as the dye-filling phenotype depends on the presence of
functional sensory cilia in the amphid neurons. These cilia only develop in the presence of DAF19C, which is responsible for activating genes required for ciliogenesis. As such, the of6 mutant
may not affect daf-19c at all, which would support evidence for a transcript beginning in exon 5.
While other lab members are currently addressing this question, the subsequent designs all
assume that daf-19c does in fact begin with exon 5. Implementation of these designs will be
carried out this summer by Debora Sugiaman.
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Figure 43: Potential daf-19c start sites. Conflicting evidence from Gabi Senti and Debora Sugiaman suggests that
daf-19c may actually begin in exon 5. Image adapted from Wang et al. 2010.

Design and Workflow Summary
The two CRISPR designs detailed here are based on work done by Paix and colleagues
(2015), who present an efficient protocol for mutagenesis that should ideally take only a few
weeks to complete. In the first design, we propose to replace the start codon of exon 5 with an
alanine codon, in the hopes that the change will not affect the functionality of DAF-19A/B, while
stalling translation of DAF-19C. The second approach incorporates a double frameshift mutation
that will knock out DAF-19B/C, but should be corrected in DAF-19A (Figure 44).
The approach that Paix and colleagues describe combines a cloning-free protocol with the
co-CRISPR method developed by Arribere et al. (2014). In this method, worms are injected with
an in vitro-synthesized Cas9-crRNA-tracrRNA complex, thus eliminating the need to clone
either the guide RNA or the repair template into an expression vector. In the co-CRISPR
strategy, two edits are made: one for the desired mutation, and one to produce a dominant marker
mutation that is easily visible in both homozygous and heterozygous worms. This marker
identifies worms that have received sufficient quantities of Cas9 protein, crRNA, tracrRNA, and
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homology repair template for at least one successful mutation, which is a strong predictor of a
second successful mutation. As such, only those populations that contain large numbers of
worms with the marker mutation need be screened for the desired edit (Figure 45). That marker
mutation can then be selected against when picking worms to initiate subsequent generations, as
it will most often be heterozygous. Paix and colleagues found that up to 70% of worms with the
marker mutation contained the second desired edit; thus, the method is highly robust. They used
a dominant dpy-10 (roller) mutation as their marker. However, as both daf-19 and dpy-10 are
located on chromosome II, this is not ideal for our project. In such cases, Paix and colleagues
recommend tagging the constitutively expressed (but nonessential) gene gtbp-1 with eGFP to
create a fluorescent marker for screening which can be easily outcrossed.
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Figure 44: CRISPR mutagenesis approaches. Figure A (mutagenesis #1) shows the location of a single amino
acid change from methionine to alanine at the start codon of exon 5, which is expected to stall translation of DAF19C without significantly affecting the other isoforms. Figure B (mutagenesis #2) shows the location of a double
frameshift mutation that removes a single base from the beginning of exon 5 and adds the same base to the end of
exon 3. This is expected to result in two frameshift mutations that will knock out DAF-19B/C while preserving the
function of DAF-19A. Green checkmarks note hypothesized functional isoforms, while red X’s show the presence
of null alleles. Figure adapted from Wang et al. 2010.
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Figure 45: Co-CRISPR strategy. (A) The marker mutation at dpy-10 is shown along with the
mutation at the locus of interest (Insertion of a fluorescent protein at the desired site). (B) Parent
worms are injected and screened for roller progeny; those with high proportions of roller worms are
termed "jackpot broods." Figure adapted from Paix et al. (2015).

CRISPR Approach #1:
We chose to replace the start codon of exon 5 (Figure 46) with alanine instead of
methionine, as both residues are nonpolar, and alanine has a very small side chain. As such,
alanine will hopefully behave in a chemically similar way to methionine when incorporated into
the fully folded protein. We used the crispr.mit.edu website to design guide RNAs near the exon
5 start codon. The program designed four possible guides (Figure 47; Table 24).

gagattattcgtaggtcgaaaacaacaatctagcaccgcgtttaatatttcatgagcactttgagttgaagaatgaagagaataatg
gaattttgaggagaaggatgattaaaaatttaaatttcgaaaattttcagaaATGGAGGTCATCCAACAC
TCGACAGACGATCCGAATGGCACGCGAGAGGAATTCGACTATAATCAAATT
GAATATGGAAAgtgagttgtgaaatataattggggagtctgaaacgtgaagtcttaaaaataaataatgaatataggcaa
agaag
Figure 46: daf-19 exon 5 and adjacent nucleotides. Exon 5 is depicted in capital letters and yellow highlighting,
while lowercase letters show the immediately adjacent intron regions. The start codon is highlighted in red. Letters
notated in bold show the sequence of nucleotides that was scanned for possible guide RNAs by the MIT CRISPR
design tool.
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A

B

C
gagattattcgtaggtcgaaaacaacaatctagcaccgcgtttaatatttcatgagcactttgagttgaag
aatgaagagaataatggaattttgaggagaaggatgattaaaaatttaaatttcgaaaattttcagaaA
TGGAGGTCATCCAACACTCGACAGACGATCCGAATGGCACGCG
AGAGGAATTCGACTATAATCAAATTGAATATGGAAAgtgagttgtgaaa
tataattggggagtctgaaacgtgaagtcttaaaaataaataatgaatataggcaaagaag
Figure 47: Sequence and location of potential crRNAs. (A) All guide RNAs were designed by the
crispr.mit.edu tool, with scores reflecting the predicted relative accuracy of each guide. Sequences are
shown 5’ – 3’, with adjacent PAM sequences in green letters. According to the program, each of the first
three guides is considered high quality. (B) The schematic shows the relative location and direction of
each crRNA. (C) Complementary sequences of the guides are shown with exon 5 and the immediately
surrounding introns. Exon 5 is shown in capital letters and yellow highlights. Guide #1 is henceforth
shown in green, guide #2 is shown in pink, and guide #3 is shown in blue.

crRNA

1
2
3

Guide sequence

PAM

Protospacer (coding
strand, 5’ – 3’)

UCGGAUCGUCUGU
CGAGUGU
AUAAUGGAAUUUU
GAGGAGA
UCGAAAAUUUUCA
GAAAUGG

TGG

ACACTCGACAGACG
ATCCGA
ATAATGGAATTTTGA
GGAGA
TCGAAAATTTTCAGA
AATGG

AGG
AGG

Offtarget
sites

Offtarget
sites in
genes

6

6

48

25

167

78

Table 24: Potential crRNA sequences. The sequence of each crRNA is shown with the corresponding protospacer
sequence and PAM sequence, as well as the number of predicted off-target sites.
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Various recommendations have been made with regards to designing efficient crRNAs. These
include the following:
1. Several papers recommend designing crRNAS with 50-75% GC content (Doench et al.,
2014, Gagnon et al., 2014). Guide #1 meets this criterion (55%), while guides 2 and 3 do
not (30% each).
2. The presence of a GG dinucleotide immediately upstream of the PAM sequence
significantly improves crRNA efficiency. A G is acceptable, but a C should not be used
in this position (Farboud & Meyer, 2015). Guide #3 meets this criterion.
3. The proximity of the cleavage site to the desired edit site is a significant predictor of
crRNA efficiency; Paix and colleagues recommend choosing crRNAs <10 bases away
from the edit site. Guide #3 meets this criterion.
4. It is preferable to use crRNAs with few predicted off-target sites. For these sites, it is
best to have at least 3 mismatches (preferably close to the PAM sequence) to minimize
the risk of an additional cut. For the three potential crRNAs, guide #1 is by far the best
choice in this regard (only 6 off target sites, all of which have 4 mismatches). Guide #2
has a significant number of off target sites, all of which have 3-4 mismatches. Guide #3
has the greatest potential for off-target effects; however, only two of the listed loci have
fewer than 3 mismatches.
Due to its proximity to the desired mutation locus and the presence of a GG dinucleotide,
we propose guide #3 to be the best candidate for CRISPR; however, we have created homology
repair template designs for both guides #1 and #3, as described below. Whichever crRNA is
used should immediately precede the universal sequence GUUUUAGAGCUAUGCUGUUUUG,
which binds to the tracrRNA in order to guide the Cas9 protein to the desired site. Thus, if guide
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RNA #1 is to be used, the full crRNA will read:
UCGGAUCGUCUGUCGAGUGUACACTCGACAGACGATCCGA.
Homology repair templates
Homology repair templates were designed based on recommendations from several sources,
which include the following suggestions:
1. Repair templates should have homology arms that are ~35 nucleotides long, and should
ideally terminate with a C or G (Paix et al., 2014).
2. Repair templates should be designed to avoid hairpins whenever possible (Paix et al.
2014). These can be tested for using an oligonucleotide property calculator.
3. Mutations should be introduced to the repair template to disrupt the crRNA sequence or
the PAM sequence, so as to prevent a second cleavage event. Paix and colleagues
recommend creating 2-4 mutations to disrupt the crRNA sequence, and note that changes
to the PAM sequence are most effective.
4. When making edits, codon bias for C. elegans should be taken into account, and should
match the original codon as closely as possible. Additionally, it is important to make
only silent mutations. Paix and colleagues also recommend avoiding changes to
noncoding regions, so as to avoid unknown regulatory motifs.
Repair template for crRNA # 3:
A repair template was designed to accompany crRNA #3 (Figure 48). This template is 75
bp long (~35 on each side of the edit), and ends with a guanine nucleotide on each end, as
recommended by Paix and colleagues (2014). Potential hairpins, while not completely
eliminated, were minimized as much as possible. The PAM sequence and protospacer region are
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modified by a total of 8 mutations, so as to avoid repeated cleavage events in the same location.
Exon-specific changes are reflected in Table 25 with their respective codon bias. Higher codon
bias values indicate that a codon will be used more frequently; as such, any introduced codons
should ideally be used at least as frequently as the original codons.

A
ggatgattaaaaatttaaatttcgaaaattttcagaaATGGAGGTCATCCAACACTCGACAGACGA
TCCGAATGG

B
gtttgattaaaaatttaaatttcggatcctttcagaaGCTGAAGTCATCCAACACTCGACAGACGAT
CCGAATGG
Figure 48: Proposed homology repair template for crRNA #3. (A) The original genomic sequence covered by
the repair template. crRNA is shown in blue, and exon 5 is shown in yellow highlighting and capital letters. (B)
Proposed homology repair template. crRNA is shown in blue, and mutations are shown in red.

Mutation #1

Mutation #2

Codon
Amino acid
Codon bias
Codon
Amino acid
Codon bias

Original codon
ATG
Methionine
1.0
GAG
Glutamic Acid
0.38

New codon
GCT
Alanine
0.36
GAA
Glutamic Acid
0.62

Table 25: Codon changes for repair template #3. Codon biases were calculated using the Codon Usage Database
at http://www.kazusa.or.jp/codon.

Among the changes built into the intron region of the protospacer is a BAM HI restriction
site (GGATCC; Figure 49). This restriction site is intended to allow easy genotyping of worms
containing the repair template by isolating the sequence immediately around the edit, amplifying
it with PCR, and performing a restriction digest. This is shown in the sequence below, with the
restriction site depicted in gray, exon 5 shown in yellow/all caps, and forward and reverse primer
sites shown in red. After PCR and restriction digest, we would expect to see a single 325 bp
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fragment in worms without a successful CRISPR edit, and two fragments (210 and 115 and bp,
respectively) in worms with a successful CRISPR edit.

ccgcttatctgtcttttcctctgtgatttgatttttttgtgttaaacttaattttttttgatggtgtacgggaagcggtaaaaggtag
accaattagaagaaggcctttgtgctctttatagagccaagcggctgtcgcttataaaataaagcttcacactaattatcta
ttatctatttcctccccctcctctgcctttgtctgctccaaacggtaattattgggttttgaggcagccggctctgtctctacctg
agattattcgtaggtcgaaaacaacaatctagcaccgcgtttaatatttcatgagcactttgagttgaagaatgaagaga
ataatggaattttgaggagaagtttgattaaaaatttaaatttcggatcctttcagaaGCTGAAGTCATCCAAC
ACTCGACAGACGATCCGAATGGCACGCGAGAGGAATTCGACTATAATCAAATTG
AATATGGAAAgtgagttgtgaaatataattggggagtctgaaacgtgaagtcttaaaaataaat
Figure 49: Mutated sequence for restriction digest. The 5’–3’ sequence including exon 5 (yellow/capital letters)
and the surrounding intron region after homology repair is shown. This sequence includes a single new BAH MI
restriction site (shown in gray) that can be used to identify the mutated sequence with PCR and restriction digest.
PCR primers surrounding the sequence of interest are shown in red.

Repair template for guide # 1:
A second repair template was designed to accompany crRNA #1 (Figure 50). This
template is 86 bp long (~40 bp on each side of the edit), and ends with a guanine nucleotide at
the 3’ end, as recommended by Paix and colleagues (2014). Potential hairpins, while not fully
eliminated, were minimized as much as possible (data not shown). While the PAM sequence is
not mutated, the protospacer region is modified by a total of 4 mutations, so as to avoid repeated
cleavage events in the same location. Exon-specific changes are reflected in Table 26 with their
respective codon bias. As with the previous template design, a BAM HI restriction site is built
into the template to allow for easy genotyping (Figure 51). After PCR and restriction digest, we
would expect to see a single 325 bp fragment in worms without a successful CRISPR edit, and
two fragments (191 and 134 bp, respectively) in worms with a successful CRISPR edit.
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A
tcgaaaattttcagaaATGGAGGTCATCCAACACTCGACAGACGATCCGAATGGCACG
CGAGAGGAATTCGACTATAATCAAATTG

B
tcggatcctttcagaaGCTGAGGTCATCCAACACTCTACTGATGATCCTAATGGCACGC
GAGAGGAATTCGACTATAATCAAATTG
Figure 50: Proposed homology repair template for crRNA #1. (A) The original genomic sequence covered by
the repair template. crRNA is shown in green, and exon 5 is shown in yellow highlighting and capital letters. (B)
Proposed homology repair template. crRNA is shown in green, and mutations are shown in red.

Mutation #1

Mutation #2

Mutation #3

Mutation #4

Mutation #5

Codon
Amino acid
Codon bias
Codon
Amino acid
Codon bias
Codon
Amino acid
Codon bias
Codon
Amino acid
Codon bias
Codon
Amino acid
Codon bias

Original codon
ATG
Methionine
1.0
TCG
Serine
0.15
ACA
Threonine
0.34
GAC
Aspartic Acid
0.33
CCG
Proline
0.2

Change
GCT
Alanine
0.36
TCT
Serine
0.21
ACT
Threonine
0.33
GAT
Aspartic Acid
0.68
CCT
Proline
0.18

Table 26: Codon changes for repair template #1. Codon biases were calculated using the Codon Usage Database
at http://www.kazusa.or.jp/codon.

ccgcttatctgtcttttcctctgtgatttgatttttttgtgttaaacttaattttttttgatggtgtacgggaagcggtaaaaggtagac
caattagaagaaggcctttgtgctctttatagagccaagcggctgtcgcttataaaataaagcttcacactaattatctattatc
tatttcctccccctcctctgcctttgtctgctccaaacggtaattattgggttttgaggcagccggctctgtctctacctgagattat
tcgtaggtcgaaaacaacaatctagcaccgcgtttaatatttcatgagcactttgagttgaagaatgaagagaataatgga
attttgaggagaagtttgattaaaaatttaaatttcggatcctttcagaaGCTGAGGTCATCCAACACTCTA
CTGATGATCCTAATGGCACGCGAGAGGAATTCGACTATAATCAAATTGAATATGG
AAAgtgagttgtgaaatataattggggagtctgaaacgtgaagtcttaaaaataaat
Figure 51: Mutated sequence for restriction digest. The 5’ – 3’ sequence including exon 5 (yellow/capital letters)
and the surrounding intron region after homology repair is shown. This sequence includes a single new BAM HI
restriction site (shown in gray) that can be used to identify the mutated sequence with PCR and restriction digest.
PCR primers surrounding the sequence of interest are shown in red.
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CRISPR Approach #2
A second CRISPR mutagenesis approach was designed to knock out daf-19b and daf-19c
by introducing a 1 bp frameshift mutation starting in exon five. This is corrected for in daf-19a
with an additional 1 bp frameshift mutation in exon 3, which adds back the deleted base and
cancels out the first mutation (see Figure 44). As DAF-19B contains an additional exon (exon 4)
between these two sites, the mutation in exon 3 will result in a frameshift that affects the
integrity of exon 4, thereby likely causing a null mutation for this isoform. The sequences below
show the specific reading frames and effects of these two mutations in DAF-19A/B/C,
respectively.
1. The WT open reading frame for the end of exon 3 and the beginning of 5 (daf-19a) is
shown below (exon 3 in yellow, exon 5 in blue):
GAT GGT ACC GTG GGA GAT GAA ATG GAG GTC ATC CAA CAC TCG ACA GAC
2. Worms with both successful mutations will add an adenine nucleotide to the end of
exon 3, and remove it from the beginning of exon 5; thus, the open reading frame will
read as follows:
GAT GGT ACC GTG GGA GAT GAA ATG GAG GTC ATC CAA CAC TCG ACA GAC
3. The WT isoform B open reading frame spanning exons 3 (yellow) and 4 (purple) reads
as follows:
GAT GGT ACC GTG GGA GAT GCG TCA GTG ATG TTA GAT CCT ACA AAG ATA
4. The exon 3 mutation will change this reading frame to the following sequence, thus
changing the amino acids in exon 4 and likely rendering the protein nonfunctional:
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GAT GGT ACC GTG GGA GAT GAC GTC AGT GAT GTT AGA TCC TAC AAA GAT
5. The WT open reading frame for the beginning of exon 5 (from isoform C, shown in
green) is as follows:
ATG GAG GTC ATC CAA CAC TCG ACA GAC GAT CCG AAT GGC ACG CGA GAG
6. The exon 5 mutation would change this reading frame to the following sequence, thus
changing all future amino acids in the isoform and rendering the protein product
nonfunctional. Additionally, it is unlikely that the protein would be translated at all,
given the lack of a start codon.
TGG AGG TCA TCC AAC ACT CGA CAG ACG ATC CGA ATG GCA CGC GAG AGG
When designing this set of mutations, splice sites were taken into account in order to
avoid producing unwanted effects due to splice errors. According to Blumenthal and Meyer
(1997), C. elegans introns obey the canonical GU-AG rule during splicing. This is to say, the 3'
end of the intron will end in an AG dinucleotide, and the 5' end of the intron will begin with a
GU dinucleotide. Additionally, C. elegans has a highly conserved extended consensus sequence
at the 3' splice site (UUUUCAG). Figure 52 shows each exon with its surrounding splice
sequences.
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daf-19a: Exon 3 and adjacent regions:
tcccatgtcttttcgacatgctaaaattcaaatcctagagtcaaatttaatgcacaagtagttcaaattttcagATTATCAAAAGAA
ACTCACAATACAATAAGCACAAGGTCTTCTTCGTCTGGAACACCTCGTAAGAAAAT
GGAGCCTGAAGATGTGAAGCCAAATATCAAGATGCTCAAGAAATCATTGCCAGTCT
CATTTCAATGTTCTAACCTAAATGATGGTACCGTGGGAGATGgtgagtttcaatcaaccacctgtt
g
daf-19a: Exon 5 and adjacent regions:
aataatggaattttgaggagaaggatgattaaaaatttaaatttcgaaaattttcagAAATGGAGGTCATCCAACACTC
GACAGACGATCCGAATGGCACGCGAGAGGAATTCGACTATAATCAAATTGAATAT
GGAAAgtgagttgtgaaatataattggggagtctgaaacgtgaagtcttaaaaataaataatgaatataggcaaagaa
daf-19c: Exon 5 and adjacent regions:
aaaaatttaaatttcgaaaattttcagaaATGGAGGTCATCCAACACTCGACAGACGATCCGAATGGC
ACGCGAGAGGAATTCGACTATAATCAAATTGAATATGGAAAgtgagttgtgaaatataattgggg
Figure 52: Exons 3 and 5 in WT daf-19A and daf-19C. Exons are shown in yellow/capital letters, and splice
sequences are shown in red letters. The ATG start codon of daf-19c exon 5 is shown in bold. Two nucleotides at
the beginning of exon 5 that are spliced differently in daf-19a and daf-19c are shown in blue.

It should be noted that there are two extra bases included in exon 5 in the daf-19a
transcripts; thus, the splice site for this isoform is two bases earlier than in exon 5. While this
conforms with the conserved 3’ splice sequence, the splice site in daf-19c is non-canonical. As
such, it is unclear whether splicing occurs immediately prior to the ATG start codon in exon 5
for all daf-19c transcripts, or whether the actual splice event occurs in the same place for both
isoforms, and the ATG codon is simply identified by the ribosome at the start of translation,
thereby determining the reading frame. Introns with 3’ AA splice sites (such as the one adjacent
to exon 5 in daf-19c) have been reported (e.g. Aroian et al., 1993), which would suggest that the
transcript from WormBase is accurate as written. However, Zhang and Blumenthal (1996) found
evidence suggesting that the UUUC portion of the 3’ splice site may be particularly important for
splice site identification; this could mean that this AA dinucleotide is present in daf-19c mRNAs,
and is simply skipped by the ribosome in favor of the adjacent start codon. We proceed with the
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assumption that the splice sites listed on WormBase are correct and will not be compromised by
the addition or deletion of a base directly adjacent to them; however, this potential discrepancy is
an important consideration.
crRNA Design
For the mutation adjacent to exon 5, it is possible to use the same crRNA that was created
in the previous mutagenesis approach, as the mutation will occur in approximately the same
location (see CRISPR approach #1). For the mutation adjacent to exon 3, the same approach
detailed in the previous CRISPR design was used to generate an appropriate crRNA. A sequence
of ~250 bp immediately surrounding the end of exon 3 was analyzed using the crispr.mit.edu
design tool. 17 potential guides were reported, and the six best sequences were considered for
predicted accuracy (Figure 53; Table 27).

A

B
GCTCAAGAAATCATTGCCAGTCTCATTTCAATGTTCTAACCTAAATGATGGTACCGT
GGGAGATGgtgagtttcaatcaaccacctgttggcattgccagaaatgatgaggccagctcgcgcagattcttgactaattagttttcg
acgcagtatacccgtaaaatttaaaagaaaataaatatgagataacggacggatagataatcaaag
Figure 53: Sequence and location of potential crRNAs. (A) All crRNAs were designed by the crispr.mit.edu
tool, with scores reflecting the predicted relative accuracy of each guide. Sequences are shown 5’ – 3’, with
adjacent PAM sequences in green letters. According to the program, each of the first six guides is considered
high quality. (B) Complementary protospacer sequences of the guides are shown with exon 5 and the
immediately surrounding introns. Exon 5 is shown in capital letters/yellow highlights. Guide #1 is
henceforth shown in green, guide #2 is shown in pink, and guide #6 is shown in blue (guides 3/4/5 not
labeled).
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Guide

1
2
3
4
5
6

Guide sequence

AGUCAAGAAUCUGC
GCGAGC
UAACCUAAAUGAUG
GUACCG
CAAUGUUCUAACCU
AAAUGA
AACCUAAAUGAUGG
UACCGU
AAUGAUGGUACCGU
GGGAGA
UUUCUGGCAAUGCC
AACAGG

PAM

TGG
TGG
TGG
GGG
TGG
TGG

Protospacer (coding
strand, 5’ – 3’)
GCTCGCGCAGATT
CTTGACT
TAACCTAAATGAT
GGTACCG
CAATGTTGTAACC
TAAATGA
AACCTAAATGATG
GTACCGT
AATGATGGTACCG
TGGGAGA
CCTGTTGGCATTG
CCAGAAA

Off-target
sites
4

Off-target
sites in
genes
4

3

2

9

7

8

5

6

3

8

6

Table 27: Potential crRNA sequences. The sequence of each crRNA sequence is shown with the corresponding
coding strand sequence and PAM sequence, as well as the number of predicted off-target sites.

We recommend using crRNA #6, as it has a GG dinucleotide directly adjacent to the
PAM sequence, has 50% GC content, is within 20 bp of the desired mutation, and has a low
number of off-target sites, all of which have at least 4 mismatches (see criteria described in
CRISPR approach #1).
Homology repair template for mutation #1 (adjacent to exon 5):
A repair template was designed to accompany the crRNA designed in the previous
CRISPR approach, which can be used here for the exon 5 mutation (Figure 54). This template is
74 bp long (~37 bp on either side of the edit), and ends with a guanine nucleotide on either end,
as recommended by Paix and colleagues (2015). A single base was deleted between the ATG
start codon and the end of the 3’ splice site. Our hope is that splicing will still occur in the same
location, although it is possible that the splice event may one or two bases upstream, and that one
or two adenine nucleotides will be included adjacent to the TGG motif; if this occurs, then the
start codon may remain intact, and the mutation will fail to produce a frameshift.
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An additional mutation was made to the PAM sequence in order to prevent repeated Cas9
binding. In the daf-19a double mutants, this will result in a silent mutation to a glutamic acid
codon (Table 28). Furthermore, a BAM HI restriction site was built into the intron portion of the
protospacer, both to disrupt binding and to create a simple marker for screening with restriction
digest. The same primers from the first CRISPR design can be used to screen for this template.

A
ggatgattaaaaatttaaatttcgaaaattttcagaaATGGAGGTCATCCAACACTCGACAGA
CGATCCGAATGG

B
ggatgattaaaaatttaaatttggatccttttcagaa__TGGAAGTCATCCAACACTCGACAGA
CGATCCGAATGG
Figure 54: Proposed homology repair template for crRNA (exon 5 mutation). (A) The original genomic
sequence covered by the repair template. crRNA is shown in blue, and exon 5 is shown in yellow highlighting and
capital letters. The splice consensus sequence preceding the exon is shown in red letters (B) Proposed homology
repair template. crRNA is shown in blue, and mutations are shown in red highlights. The mutation of significance
is a single base deletion at the beginning of exon 5. The splice consensus sequence preceding the exon is shown in
red letters.

Mutation #1
Mutation #2

Codon
Amino acid
Codon
Amino acid
Codon bias

Original codon
ATG
Methionine
GAG
Glutamic Acid
0.38

Change
TG
Frameshift
GAA
Glutamic Acid
0.62

Table 28: Codon changes for the exon 5 repair template. Codon biases were calculated using the Codon Usage
Database at http://www.kazusa.or.jp/codon.

Homology repair template for mutation #2 (adjacent to exon 3):
An additional repair template was designed to accompany crRNA #6 (Figure 55). This
template is 75 bp long (~37 bp on either side of the edit). A single base (adenine) was added
between the end of exon 3 and the adjacent splice site. Additional mutations were made to the
PAM sequence and protospacer within the intron; these serve to disrupt repeated binding and to
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create a BAM HI restriction site for screening (Figure 56). After PCR and restriction digest, we
would expect to see a single 489 bp fragment in worms without a successful CRISPR edit, and
two fragments (336 and 153 bp, respectively) in worms with a successful CRISPR edit.

A
AATGTTCTAACCTAAATGATGGTACCGTGGGAGATGgtgagtttcaatcaaccacctgttgg
cattgccagaaa

B
AATGTTCTAACCTAAATGATGGTACCGTGGGAGATGAgtgagtttcaatcaacggatccttg
gcattgccagaaa

Figure 55: Proposed homology repair template for crRNA (exon 3 mutation). (A) The original genomic
sequence covered by the repair template. crRNA is shown in blue, and exon 5 is shown in yellow highlighting and
capital letters. The splice consensus sequence following the exon is shown in red letters (B) Proposed homology
repair template. crRNA is shown in blue, and mutations are shown in red highlights. The mutation of significance
is a single base addition at the beginning of exon 3. The splice consensus sequence following the exon is shown in
red letters.

gtggtgtgcttgtcggcttggagtgggtggagtgataacagaagcccgattcggagtccctttctgcgtttccatggatacgggg
aataatgaaaacctcgcatccgcttccccccacttttgtcatctcatactactactatttagtttatttgttaatttttcatatcccatgtct
tttcgacatgctaaaattcaaatcctagagtcaaatttaatgcacaagtagttcaaattttcagATTATCAAAAGAAA
CTCACAATACAATAAGCACAAGGTCTTCTTCGTCTGGAACACCTCGTAAGAA
AATGGAGCCTGAAGATGTGAAGCCAAATATCAAGATGCTCAAGAAATCATT
GCCAGTCTCATTTCAATGTTCTAACCTAAATGATGGTACCGTGGGAGATGAgt
gagtttcaatcaacggatccttggcattgccagaaatgatgaggccagctcgcgcagattcttgactaattagttttcgacgcagt
atacccgtaaaatttaaaagaaaataaatatgagataacggacggatagataatcaaaggtgtggtggcgagtctagaggaagt
aagagaaccta
Figure 56: Mutated sequence for restriction digest. The 5’ – 3’ sequence including exon 3 (yellow/capital letters)
and the surrounding intron region after homology repair is shown. This sequence includes a single new BAM HI
restriction site (shown in gray) that can be used to identify the mutated sequence with PCR and restriction digest.
PCR primers surrounding the sequence of interest are shown in red.

In summary, this design requires two simultaneous CRISPR mutagenesis events that will
create two frameshift mutations, in which the first adenine nucleotide in exon 5 is deleted from
its present location and added to the end of exon 3. This will allow transcripts of daf-19a to
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retain the same amino acid sequence as in WT worms, while resulting in nonfunctional DAF19C, and likely DAF-19B as well. The obvious disadvantage to this approach is that it requires
two simultaneous edits; however, work by Paix et al. (2015) and others has shown that effective
crRNAs may be efficient enough to produce the desired double mutagenesis, particularly when a
co-CRISPR approach is used (Arribere et al., 2014). Additionally, this frameshift mutation will
almost certainly knock out DAF-19C, assuming that the splice sites listed on wormbase.org for
daf-19c are accurate. With CRISPR approach #1, it is possible that replacing the first start codon
with another amino acid will be insufficient to knock out the protein, as there are other in-frame
methionine codons in close proximity that could potentially be used as alternate start sites.
While this would result in a somewhat truncated protein product, there is no guarantee that it will
results in a null mutant. Thus, if the two crRNAs created for CRISPR approach #2 prove to be
efficient, the double frameshift approach may be more likely to produce the desired phenotype.
Cas9 purification optimization
Although the previously described CRISPR designs will be implemented this summer by
Debora Sugiaman, we had originally planned to complete these experiments at Lawrence. As
such, we optimized a Cas9 purification protocol described by Paix and colleagues (2015) to
produce the Cas9 protein necessary for CRISPR mutagenesis (Appendix B). With a few
modifications, their procedure proved to be efficient and relatively easy to implement.
Members of the Seydoux lab generously provided us with a strain of E. coli that had been
transfected with a plasmid (nm2973) that contained the coding sequence for Cas9 protein, a T7
viral promoter just upstream of the coding sequence, and a carbenicillin resistance gene. These
bacteria can be grown in media containing carbenicillin (an antibiotic), to select for only those
cells that contained the desired plasmid. The T7 promoter allows selective induction of the gene
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in the presence of IPTG, causing the bacteria to produce an overabundance of Cas9 protein
(Figure 57). After allowing the bacteria to proliferate in carbenicillin/luria broth media to the
appropriate population density, IPTG was added and the bacteria were allowed to grow
overnight.

Figure 57: Cas9 induction by T7 promoter. IPTG binds to the T7 promoter to induce transcription of the Cas9
coding sequence that follows, resulting in overproduction of the protein.

After allowing the bacteria to produce Cas9, the culture was pelleted and resuspended,
and sonication in the presence of protease inhibitors was used to lyse the cells. The cleared
lysate was batch bound with Ni-agarose beads for 25 minutes. While Paix and colleagues
suggest batch binding for 45 minutes, preliminary experiments indicated that an excess of other
proteins bound to the beads, resulting in a more laborious purification procedure. As such, we
recommend shortening the time spent on this step.
Following the batch binding step, Ni affinity chromatography was used to isolate the
Cas9 protein. Ni affinity chromatography works by binding proteins with histidine tags to nickel
beads while allowing other contaminants to run through the column. The Cas9 coding sequence
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in our plasmid contains a 6X histidine tag; thus, when this Cas9 comes in contact with the beads,
it sticks to the column while other proteins are washed away with excess buffer (Figure 58). We
found that it was unnecessary to wash the beads with 100 mL of buffer during this step, as
recommended by Paix and colleagues; rather, half this volume was sufficient. The Cas9 protein
was then eluted in 1 mL fractions with a buffer containing a high concentration of imidazole.
Imidazole serves to outcompete the 6X histidine tag on the Cas9 protein, thus causing it to come
off the beads and flow through the column into the eluent. We found that this step worked best
when we doubled the concentration of imidazole suggested by Paix et al., as it caused the Cas9
protein to come off the beads all at once within a few fractions, rather than trickling off slowly.
Individual fractions were then tested for the presence of the protein using SDS-page, which
confirmed the presence of a protein that was the correct size (Figure 59).

Figure 58: Ni-affinity chromatography. The target protein (blue arrows) binds preferentially to the Ni beads,
shown in yellow. Other proteins flow through the column during the wash step. The target protein is then eluted
using a buffer containing imidazole, which is better able to bind the Ni beads and thus outcompetes it. Figure
adapted from bio-rad.com/en-us/applications-technologies/introduction-affinity-chromatography.
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Figure 59: Cas9-containing fractions after elution. SDS-page was used to show the presence of a protein ~160
kDa in size, thus demonstrating the presence of Cas9.

After elution, fractions containing Cas9 were pooled and run over a Q Sepharose column
to remove contaminating nucleic acids. Q Sepharose beads are positively charged, and thus bind
to the negative phosphate backbone characteristic of DNA and RNA. As Cas9 protein is
positively charged, it flows directly through the column. Following this step, the protein was
dialyzed using a Pierce Cassette (Figure 60). These cassettes are comprised of a membranebound sac that is permeated with pores to allow material smaller than 100 kDa to pass through.
The eluent was injected into the sac and allowed to dialyze overnight in buffer, then transferred
to a second cassette and allowed to dialyze again. During dialysis, fluids and small particles pass
through the membrane by osmosis until each side of the membrane contains an isotonic solution.
The two-step dialysis process allows the vast majority of small contaminants (e.g. partially
degraded proteins, etc.) to diffuse out of the Cas9-containing eluent, which is then removed with
a syringe.
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Figure 60: Dialysis by Pierce Cassette. The cassette membrane is permeated with pores that allow material
smaller than 100 kDa in size to pass through (shown in red and yellow circles). The Cas9 protein (purple circles), at
160 kDa, is too large to flow through.

As a final step, the Cas9 protein was concentrated to ~10 mg/ml and frozen in 5 µl
aliquots at -80oC. Our final run of the protocol yielded 37 aliquots of 5 µl at a concentration of
9.84 mg/ml. As such, we are able to confirm the efficacy of the procedure outlined in Paix and
colleagues (2015). Purification is considerably more cost-effective than using commercial Cas9,
which can cost hundreds of dollars for a single injection; as such, this procedure may prove
useful for future CRISPR experiments done at Lawrence.
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DISCUSSION
The primary aim of this study was to identify new gene targets of DAF-19, with a
particular focus on genes that are involved in neuronal processes. We wished to go beyond
previous studies that have focused on the role of DAF-19 in ciliogenesis to explore targets that
might play a role in synaptic maintenance. Additionally, we were interested in identifying which
isoforms of DAF-19 control each of these targets. This focus stemmed from work done by Senti
and Swoboda (2008), which found a novel indirect role for DAF-19 in regulating synaptic
proteins.
In order to identify putative targets, Elizabeth De Stasio and Prasad Phirke performed
three microarray analyses of adult, L1 larvae, and 3-fold stage embryos in daf-19(WT) and daf19(m86) backgrounds. Previous studies aiming to identify DAF-19 target genes focused on the
identification of x-box containing genes. Our study used a less biased approach, beginning with
a comparative transcriptome analysis. This resulted in a list of 177 differentially expressed
genes, of which 30 were selected from this list for further analysis. Gene selection was based on
several factors, such as the degree to which the gene was differentially expressed (< 0.5 or >1.5
fold change), whether it had any known neuronal functions, the presence of an x-box motif in its
promoter region, and homology to human genes. Transcriptional fusions of each gene’s control
region with GFP were made, so as to explore each gene’s expression pattern. The present study
sought to analyze five of these 30 genes for DAF-19 dependence.
Each transcriptional fusion was carefully analyzed for GFP expression using confocal
microscopy. Isogenic strains were studied first in WT and m86 backgrounds to confirm the
presence of differential GFP expression before determining isoform-specific mechanisms of
control. Once these expression patterns had been characterized, a series of new isogenic strains
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in different daf-19 genetic backgrounds were generated, including tm5562 and of5, (both of
which would affect DAF-19A/B production) and of6 (affecting DAF-19B). Additionally, rescue
experiments using daf-19a and/or daf-19c cDNAs were completed to better elucidate the effects
of these respective isoforms on gene regulation. Of the five genes studied, one (T01B11.2) is
clearly regulated by DAF-19C, while two additional genes (T07F10.1 and del-4) show some
DAF-19 dependence; however, we conclude that this is not the sole regulating factor for either
gene. A fourth gene, srd-61, showed expression patterns independent of DAF-19, while a final
gene, decr-1.1 showed no definitive expression pattern in either genetic background.
Confidence in reporter expression and DAF-19 dependence
While transgenic reporters are efficient and useful tools for determining gene expression
patterns, there are various limitations and potential confounding factors that should be
considered when interpreting the data reported here. Firstly, the transgenes themselves are not
genomic DNA; rather, each constitutes an extrachromosomal plasmid array constructed in the
worm gonad following microinjection. The level of transgene expression depends on the number
of plasmid copies that assemble into a transgene array in the worm, and the degree to which they
are stably inherited. As such, expression levels and plasmid integrity for each gene may vary
from injection to injection. Stability issues with certain transgenes were quite apparent, as some
were inherited much more readily than others from one generation of worms to the next. To
minimize the problem of mosaicism, we created isogenic strains in the desired daf-19
backgrounds by mating hermaphrodite worms from a single transgenic line with male daf-19
mutants; thus, the same transgenic array in all strains was inherited from a single microinjected
worm. This served to normalize expression across daf-19 phenotypes, although the results are
not necessarily representative of the strain’s “true” expression pattern.
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In addition to the question of isogenicity, it should be noted that other factors might affect
control of transgenic expression. For instance, transcriptional fusions were made based on the
assumption that each gene’s control region was contained within a region 2kb upstream of that
gene’s start codon, and that any regulation by DAF-19 would affect this region only. This is
generally considered the standard for identifying control regions near a coding sequence;
however, distal sequences that bind enhancer or repressor elements have been found far upstream
or downstream of start codons for many genes (Wenick & Hobert, 2004). It is possible that
some of the genes studied might be regulated by daf-19 via sequences that were not contained
within the transcriptional fusions, thus causing us to underreport the regulatory effects of DAF19. Furthermore, plasmid-based expression patterns do not reflect the epigenetic conditions in
which genes are regulated in vivo. Thus, it cannot be assumed that these experiments reflect all
aspects of gene regulation.
It should be noted that all strains used, whether designated WT or mutant for daf-19,
were studied in a daf-12-/-, and sometimes him-5-/- genetic background. daf-19(m86) mutants
are dauer constitutive, meaning the vast majority of worms will enter the dauer developmental
pathway as L2 larvae rather than maturing to adulthood. As this would prevent us from
completing the vast majority of experiments, it was necessary to study worms in a daf-12-/background, which prevents worms from entering the dauer pathway. This was standardized
across all strains in all backgrounds for daf-19. Additionally, many strains were him-5-/-, a
mutation that produces an abundance of males; these were used to complete matings. For
specific genotypes of each strain, see Table 1 (methods). While neither of these mutations is
known to affect daf-19 behavior or any of the target genes studied, it remains a possibility that
they may have skewed our results.
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Finally, it should be noted that without the presence of a known co-localizing marker, all
tissue identification relied on subjective judgment. We used representative images from
wormatlas.org that included neuronal schematics and confocal images as anatomical references.
While some tissues (e.g. intestines and pharyngeal muscle) were very easy to identify, others
were considerably less clear. The neuronal cell bodies in the isthmus region of the pharynx
proved particularly challenging, as many of these cells with similar morphology are located in a
compact space, and are easily mistaken for one another. Furthermore, neuronal positions are not
absolute, as cell bodies can migrate to slightly different locations during development. GFP
expression levels also varied considerably due to mosaicism, such that it was at times difficult to
determine how many neurons were fluorescing in a particular image.
Expression pattern of T01B11.2
Many tissues expressing T01B11.2::GFP could be confidently identified in both daf19(WT) and daf-19(m86) worms; these included the intestine, pharyngeal muscle, hypodermis,
muscle in the body wall and arms to the nerve ring, and rectal glands. Additionally, clear
differential expression in two to four neurons in the isthmus region of the pharynx was visible
when comparing expression of the same transgene array in daf-19(WT) and daf-19(m86) strains.
However, identification of these neurons these proved quite challenging, in part because the level
of GFP expression in other tissues often obscured these neurons. It was not always clear how
many of these neurons were fluorescing, as they varied in intensity and were often obscured by
the much brighter hypodermis; however, it seems most likely that the four cell bodies observed
constitute two neuron pairs.
Once differential expression was identified in daf-19(WT) and daf-19(m86) backgrounds,
we created a series of isogenic transgenic strains in the daf-19(tm5562), daf-19(of5), and daf-
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19(of6) backgrounds. The first two strains showed a phenotype resembling daf-19(WT) worms,
indicating that the DAF-19 isoforms affected by each of these alleles were not responsible for the
differential expression of T01B11.2::GFP. As tm5562 and of5 both affect DAF-19A/B, this
suggests that T01B11.2 is regulated specifically by DAF-19C. Additionally, recent data from a
rescue experiment adding a daf-19c cDNA construct to worms with an m86 background showed
a WT phenotype. It should be noted that only eight worms from this strain have been imaged so
far; however, the preliminary data are consistent with findings from earlier strains. It was not
possible to repeat the same experiment with daf-19a cDNAs due to the overabundance of
fluorescence in non-neuronal tissue, which obscured the green transgenic marker used to identify
daf-19a::daf-19(m86) worms. However, this experiment is not critically important, given the
considerable evidence indicating DAF-19C dependence.
In spite of the apparent clarity of these findings, data from the daf-19(of6) strain yielded
highly unexpected results. Of the worms imaged, 25% showed a WT phenotype, 50% showed
an m86 phenotype, and 25% showed a variety of novel expression patterns. These included a
complete lack of GFP expression in tissues such as the hypodermis and intestines (which nearly
always expressed the transgene in other strains), and significant up-regulation of the transgene in
other isthmus neurons. While only 24 worms from this strain were imaged, the degree of
variability observed was striking. It is possible that this indicates a role for DAF-19B in the
expression of T01B11.2, as this is the only isoform affected by the of6 mutation. However, if
this were truly the case, we would expect to see a more clear-cut WT or m86 phenotype, rather
than a mix of the two. A second possibility is that we have uncovered a previously unknown
control region in exon 4, which is disrupted by the mutation. This could produce highly variable
daf-19 transcription, thus affecting its downstream targets and producing the various expression
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patterns. More worms should be imaged in order to clarify these phenotypes, and it would be
useful to compare them with of6 expression patterns observed in other DAF-19 dependent genes,
to see whether the unusual degree of phenotypic variability is restricted to this strain.
Identification of differentially expressed neurons
A dye-filling assay confirmed that GFP did not co-localize with any of the dye-filling
amphid neurons, thus eliminating these six candidates as the site of T01B11.2::GFP expression;
however, the neurons of interest frequently appeared either directly anterior or posterior to the
three dorsal-most dye filling neurons (ASK, ADL, and ASI). This narrowed the range of
possible neurons to 10-15 nearby cells. As initial images suggested that the neurons in question
did not connect to the nerve ring, URX was considered to be a strong candidate, given its
location just anterior to ASK and its distinctive processes; however, this possibility was
eliminated through use of a double transgenic strain containing an mCherry marker in the URX
neuron, which did not co-localize with GFP. Additionally, one image collected from the daf19(of6) strain, in which the transgene had been lost or silenced in most non-neuronal tissues,
allowed us to more clearly visualize the morphology of the two pairs of neurons. Interestingly,
this image showed both pairs connecting to the nerve ring, a fact obscured by GFP expressed in
the body wall muscle arms present in this region of most other T01B11.2::GFP worms.
Additionally, as evidence indicated that T01B11.2 is very likely to be controlled by daf-19c, we
realized that the cells of interest must be ciliated sensory neurons, as these alone express the daf19c isoform (Senti & Swoboda, 2008). This allowed us to narrow the field to 14 ciliated sensory
neurons in the mid isthmus region. The dendrite morphology of these candidates was assessed,
and neurons with processes that did not match those seen in our images were eliminated.
Finally, a second marker strain was generated by crossing worms expressing an mCherry marker
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in all cholinergic neurons, and we were able to confirm that the neurons of interest were not
cholinergic, as GFP did not co-localize with mCherry. This left us with three possible neuron
pairs: ASG, AWA, and CEP. Of these, ASG and AWA were considered to be the best choices,
as their positions relative to the dye-filling amphid neurons were closest to those observed for the
neurons of interest.
Known functions of the ASG and AWA neurons
The glutamatergic ASG neuron pair consists of two sensory ciliated neurons, which play a
role in chemosensation and taste (Pocock & Hobert, 2010). Additionally, they have been shown
to play a role in lifespan regulation, as worms lacking functional ASG neurons live longer
(Alcedo & Kenyon, 2004). The AWA neurons are also ciliated; these play an odorsensory role
(Bargmann et al., 1993). Additionally, AWA is one of three key pairs of sensory neurons needed
for sexual attraction in males (White & Jorgensen, 2012). Many of these functions
(chemosensation, olfaction, taste) rely on the presence of cilia; as such, daf-19 dependent
expression in these neurons is consistent with the protein's known roles in ciliogenesis.
Hypothetical roles for T01B11.2 in a DAF-19 mediated gene pathway
T01B11.2 codes for a protein that is not known to be involved in ciliogenesis or cilia
maintenance. Very little is known about its function, although is it thought to have transaminase
activity. Such activity is critical for amino acid metabolism, which occurs in cells throughout the
body; we therefore find no clear reason why T01B11.2 would be differentially expressed in these
particular neurons. As T01B11.2 expression appears to be linked to DAF-19C, this result does
not provide evidence to support Senti and Swoboda’s hypothesis that DAF-19A/B regulate
neuronal functions in non-ciliated neurons. It is possible that we have uncovered a novel role for
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DAF-19C in regulating genes unrelated to either ciliogenesis or synapse maintenance; however,
this is merely speculation. It may be the case that DAF-19 and T01B11.2 do not interact at all,
and T01B11.2 is actually activated by an unknown downstream target of DAF-19C, which
would also be differentially expressed in daf-19(WT) vs. daf-19(m86) backgrounds.
Expression pattern of T07F10.1
T07F10.1::GFP expression was confidently determined through comparison of
representative confocal images with diagrams from wormatlas.org. Alex Hurlburt previously
identified expression in the excretory system, pharynx, and several neurons in the head and tail,
which he identified to be URX, SABD, PDA, PLM, and DVA/DVB. These identifications were
confirmed through comparison with wormatlas.org resources, and URX expression in particular
was definitively confirmed by generating a double transgenic strain that included an mCherry
marker expressed in the URX neuron.
Between the daf-19(WT) and daf-19(m86) strains, GFP expression in the URX neuron
decreased by 30 percentage points, while expression in the SABD neuron decreased by 49
percentage points. Although Alex Hurlburt was not convinced that these changes indicated true
daf-19 dependence, we elected to further study the gene in various daf-19 backgrounds in order
to see whether this gap in expression rates persisted. We found that both neurons expressed GFP
more frequently in daf-19(tm5562) and daf-19(of5) backgrounds than in WT worms, indicating
that the daf-19a/b isoforms were not responsible for activating expression of the transgene in
these cells. Additionally, the daf-19c rescue strain showed GFP expression in 94% of the SABD
and URX neurons. These preliminary data suggested the possibility that this gene is regulated by
DAF-19C. However, the daf-19a rescue strain showed GFP expression in URX 68% of the time
and SABD 72% of the time, a much higher proportion than was seen in the daf-19(m86) strain.
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One interpretation of these data is that T07F10.1 is partially regulated by DAF-19C, but DAF19A over-expression can also increase transgene expression. It is also possible that the
differences we see in transgene expression in the m86 and WT backgrounds are just variability in
gene expression and not due to the genetic background.
It should be noted that due to time constraints, a relatively small number of worms was
imaged for each strain, and it is unlikely that the proportions of GFP expression reported for each
daf-19 background are truly representative. In order to more confidently assess the possible
regulatory effects of DAF-19 on T07F10.1, more data are needed to establish representative
expression profiles. Additionally, we have not ruled out the possibility that DAF-19B is
responsible for regulating T07F10.1 in these neurons. This will be addressed by creating a
transgenic strain in a daf-19(of6) background, which is null for daf-19b only. If these worms
express an m86-like phenotype (significantly decreased expression in URX and SABD), this
would suggest that DAF-19B regulates expression of T07F10.1. It is also possible that this gene
is regulated by both DAF-19 and some other unknown transcription factor, which could explain
the variation in expression levels. However, at this time we are unable to conclusively state that
T07F10.1 is solely DAF-19 dependent.
Expression pattern of srd-61
Of all the genes imaged, srd-61 allowed for the most confident tissue identification. A
single pair of neurons in the isthmus and two pairs of tail neurons fluoresced in 100% of worms
imaged in both the m86 strain and its isogenic WT partner. These were easy to identify, as all
three neuron pairs co-localized with dye-filling neurons. Based on their position relative to the
other amphid neurons, the cells observed in the head were determined to be the ASH pair.
Additionally, two dye-filling phasmid neurons expressed GFP. As the tail has only two such

Mueller, 108

pairs of neurons, it was immediately apparent that the GFP-expressing neurons must be PHA and
PHB. As expression patterns were identical between WT and m86 worms, we conclude that srd61 is not DAF-19 dependent. This is inconsistent with the microarray data reported for this gene,
which showed significant up-regulation in daf-19(m86) worms. However, a wide variety of
factors could have affected this result, including unknown mutations or epigenetic differences in
the particular worms used in the microarray. Ultimately, our results reveal how unreliable such
data are without more rigorous verification.
Additionally, our preliminary results from this gene show how important it is to use only
isogenic strains when comparison expression patterns. Initially, we imaged two lines of worms
which had been separately injected into either daf-19(WT) or daf-19(m86) backgrounds. While
these showed fluorescence in the same neuron, the frequency of expression was variable, and we
initially believed we had found a new DAF-19 target. However, when an isogenic strain for one
of these lines was produced, it immediately became clear that this was not the case, as ASH
fluoresced 100% of the time in both lines. This discrepancy is very likely to have arisen from
variable stability or inheritance of the transgenic plasmid, and highlights the fact that
transcriptional fusions are by nature subjective. As such, it is important to replicate initial results
in a second line.
Expression pattern of del-4
Expression patterns for del-4 were highly mosaic, and could not be definitively
elucidated. In both daf-19(WT) worms and the isogenic daf-19(m86) strain, neuronal expression
was observed in up to eight neurons in the isthmus region of the pharynx, and up to four tail
neurons. Additionally, faint intestinal expression was observed in 60% of WT animals and 76%
of m86 animals. It was frequently difficult to determine how many neuronal cell bodies were
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fluorescing in an animal, as they exhibited highly variable levels of GFP expression. While
these judgments were by nature subjective, efforts were made to control for this by repeatedly
reanalyzing data for all images without reference to previous records, and averaging the
perceived number of fluorescent neurons from separate days.
One of the most commonly visualized neurons included a pair in the mid-isthmus region
of the pharynx that extended a long dendrite to the nose and connected to the nerve ring;
additionally, GFP expression in this cell did not co-localize with any dye-filling neurons. This
morphology resembled the ASE neuron pair, a hypothesis supported by Echtberger and
colleagues, who previously identified del-4 expression in this cell (2007). ASE is a ciliated
sensory neuron that plays a role in taste sensation. As daf-19 regulates ciliogenesis, it would be
reasonable to expect its expression in this neuron. However, it should be noted that without a colocalizing marker, it is impossible to conclusively determine whether this identification is
correct.
An additional pair of neurons, located just posterior to the base of the nerve ring, also
frequently fluoresced in WT and m86 backgrounds. GFP did not co-localize with any amphid
neurons, and the cell’s identity was impossible to definitively elucidate. The range of
possibilities was reduced to five neurons with similar characteristics; these were AIA, AIB,
RMDD, RMFL, and RMH. However, no further conclusions can be drawn at this time regarding
the identity of these cells.
Intermittent GFP expression in up to four tail neurons was also observed in ~50% of WT
and m86 worms. These were hypothesized by Prasad Phirke to be PQR and PHA, based on
preliminary fluorescence microscopy. PQR neurons extend a short ventral cord process and an
additional phasmid process in opposite directions away from the cell body, and are located just
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posterior to the anus. As one of the tail neurons frequently exhibited this distinctive
morphology, it was identified as such with relative confidence. The other neurons resembled
either PHA or PHB, two dye-filling phasmid neurons with a single process extending posteriorly.
These should have been relatively easy to identify with a dye-filling assay; however, we failed to
find any worms expressing GFP in these neurons on days when dye-filled animals were imaged.
The experiment would need to be repeated to confirm co-localization; however, as the neurons
do not exhibit DAF-19 dependent expression of GFP, this identification is not a priority.
There was no clear difference in expression between WT and m86 strains with regards to
which neurons fluoresce, and as such, the gene is unlikely to be DAF-19 dependent. However, it
should be noted that the daf-19(m86) strain exhibited statistically significant age-dependent
expression levels. L1/L2 worms showed GFP expression in an average of 3.58 isthmus neurons
(standard deviation = 1.06), while each progressively older group showed less expression, with
adults demonstrating fluorescence in an average of 1.67 neurons (standard deviation = 0.78).
However, WT worms did not show the same trend. The relatively low numbers of worms
observed in this strain (N=25) may have obscured this effect, and significantly more animals
need to be imaged to draw further conclusions. However, the preliminary finding is quite
interesting, as del-4 defects have been shown to result in neurodegeneration. It is possible that
this gene is misregulated in daf-19(m86) worms, resulting in a degenerative phenotype. While
an absence of GFP fluorescence does not necessarily indicate neurodegeneration, there is a
definite possibility that the change in fluorescence could indicative of neuronal damage.
Interestingly, the microarray data actually found lower expression of del-4 in L1 worms,
indicating that the gene is down-regulated in young animals. This could indicate that DAF-19
ordinarily suppresses del-4 expression in young worms, and that neurodegenerative phenotypes
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result from its misregulation. We recently generated two new isogenic strains containing del4::GFP in daf-19(tm5562) and daf-19(of5) backgrounds, which will be used to further
investigate the possibility that daf-19 mediates age-dependent expression of del-4 in the isthmus
neurons.
CRISPR design
One of our primary challenges in determining isoform-specific DAF-19 dependence
stems from our lack of a daf-19c knockout mutant. Such a tool would prove extremely useful in
determining whether particular genes are regulated by this isoform, as opposed to DAF-19A/B.
We would expect such worms to demonstrate an m86 phenotype if a target gene is regulated by
DAF-19C, and a WT phenotype if the target gene is regulated by DAF-19A/B. However, as the
sequence for daf-19c is entirely conserved in the two long-form isoforms, any mutation specific
to daf-19c must avoid changing any of the shared exons in a manner that will affect expression
of daf-19a/b. We designed two mutagenesis approaches to circumvent this problem. The first
seeks to stall translation of DAF-19C by replacing its initial methionine with alanine, in the
hopes that this will prevent the ribosome from recognizing a start site. While the change to
alanine will produce a single nucleotide polymorphism (SNP) in daf-19a/b, we hope that
alanine’s small size and nonpolar quality will not significantly affect the structure of the protein.
The second mutagenesis approach relies on two frameshift mutations: one at the
beginning of exon 5, and a second shift at the end of exon 3 to correct the first mutation. It
should be noted that while this will entirely disrupt the daf-19c isoform, it is possible that
translation could still occur in a different reading frame, beginning at a second methionine codon
that occurs 52 residues into the protein. While a deletion of this size seems likely to still result in
a nonfunctional protein, this cannot be determined for certain. daf-19b will also be disrupted, as
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the exon 3 frameshift will produce a new stop codon at the end of exon 4, thus severely
truncating the protein. Following mutagenesis, it will be necessary to confirm these phenotypes.
The presence of functional DAF-19C could be determined with a simple dye-filling assay, as
worms with a null mutation in this isoform will lack cilia and thus be unable to dye fill. Of
course, the challenge here will be determining whether DAF-19A retains its function. As we
currently have no assay to identify this, it will be necessary to generate and sequence cDNAs
from spliced mRNA transcripts of this isoform. If the sequence from the mutant exactly matches
the sequence of this transcript in WT worms, the protein should function normally. A similar
approach could be used to characterize the DAF-19B protein, which we expect to be truncated at
the end of the 4th exon.
Once these mutations are successfully created, it will be interesting to see what effects
they have on genes we have previously identified to be DAF-19 dependent. In T01B11.2::GFP
worms, we would expect these mutations to result in an m86 phenotype, as evidence currently
points toward DAF-19C mediated expression. This experiment could be done in place of the
daf-19a rescue that we were unable to complete for this strain, due to its excessive GFP
expression. We would not expect these mutations to have any effect on srd-16::GFP worms, as
the transgene is not regulated by DAF-19. The T07F10.1 and del-4 transgenes both showed
inconclusive expression patterns, and it would be very interesting to see whether these mutations
produce any effect. If T07F10.1 does in fact turn out to be regulated by DAF-19C, we would
expect to see significantly decreased expression in the URX and SABD neurons. The effects on
del-4 cannot be determined until further data regarding a possible age-dependent phenotype are
collected in tm5562 and of5 genetic backgrounds.
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Future directions:
A variety of further experiments are needed to better understand the role that daf-19 plays
in regulating the five genes studied. As the initial strains containing the decr-1.1::GFP
transgene showed no GFP expression in either daf-19(WT) or daf-19(m86) worms, we will begin
by imaging a second pair of strains which were separately microinjected. If these show no
fluorescence, it may be necessary to redesign the transgene, as the promoter region may not be
fully captured. We would also like to generate strains containing the T07F10.1 and del-4
reporters in an of6 background, both to determine whether DAF-19B has any effect on
expression and to look for any unusual fluorescence patterns (possibly indicative of a disrupted
control region). Additionally, we wish to better identify neuronal expression with additional colocalization markers. We recently obtained a new strain that fluorescently labels the nuclei of
cholinergic neurons using mCherry. This could prove to be a highly useful marker, either for colocalization with hypothesized neurons, or as a positional reference. If our hypothesized neurons
do not show mCherry co-localization, this will allow us to rule out the cholinergic neurons as
candidates, thus greatly reducing the number of possible cells.
In addition to better characterizing expression patterns and neuronal identification, it
would be useful to approach the question of DAF-19 dependence with a new approach, such as
chromatin immunoprecipitation (ChIP). This technique involves crosslinking a protein of
interest (in this case DAF-19) with any DNA to which it binds, shearing the bound DNA into
fragments, selecting for those bound to the protein via immunoprecipitation, and then sequencing
the resultant DNA to determine which genes were bound (Collas, 2010). This experiment would
confirm whether the target genes that we have identified are in fact targets of DAF-19, or
whether they are actually regulated indirectly, that is, downstream of this transcription factor.
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Additionally, it may reveal novel genes that interact with DAF-19, which were not identified by
transcriptome analysis.
Finally, it would be interesting to explore the effects of null mutations in the genes found
to be regulated by DAF-19. Many of these genes are minimally characterized, and further data
regarding their null phenotypes could further elucidate whether they play a role in synaptic
maintenance or other neuronal processes, and if so what this role entails. These data could be
used to elucidate the daf-19 gene pathway proposed by Senti and Swoboda (2008), which
predicts that DAF-19 plays an indirect role in mediating neuronal function.
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CONCLUSIONS
Transgenic GFP reporters for the genes T01B11.2, T07F10.1, srd-61, del-4, and decr-1.1
were studied for daf-19 dependent expression. Of these, T01B11.2 showed clear daf-19
dependence in the ASG and AWA sensory neurons. T07F10.1 and del-4 are partially regulated
by daf-19, although we conclude that this is not the sole factor controlling their expression.
T07F10.1 exhibited potentially differential expression in the URX and SABD neurons, and the
del-4 reporter showed age-dependent expression in ASE and several other neurons in the isthmus
region of the pharynx in a daf-19(m86) background. srd-61 expression is entirely independent of
daf-19, and no conclusions can be drawn about the relationship between daf-19 and decr-1.1 due
to a lack of decr-1.1::GFP expression in all imaged strains.
The T01B11.2 and T07F10.1 reporters were studied in various daf-19 mutant strains in
which the DAF-19A/B isoforms are presumed to be defective, and rescue experiments for these
transgenes were completed using cDNAs for daf-19a/c. We can conclude that T01B11.2 is
regulated by DAF-19C in particular, and it is likely that T07F10.1 is also partially regulated by
this isoform. We also report two new CRISPR mutagenesis designs for a DAF-19C-specific
knockout mutant, as well as the successful optimization of a Cas9 purification protocol provided
by the Seydoux Lab. While the data provided here do not support Senti and Swoboda's
hypothesis that DAF-19A/B play a role in regulating synaptic proteins, we can report DAF-19C
dependence in at least one and possibly two novel genes which are not known to be related to
ciliary function. Interestingly, both of these genes play roles in amino acid metabolism. While
future work may link their functions to ciliary maintenance, it is also possible that we have
uncovered an entirely new role for DAF-19C.
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APPENDICES
Appendix A: Dye filling Assay
1. Wash worms off plate with 1 mL M9 buffer, and allow them to settle in an Eppendorf tube.
2. Remove supernatant and rinse worms with 1 mL M9 buffer. Repeat this step if the plate has
excessive bacterial growth.
3. Remove supernatant. Add 0.5 mL M9 buffer and 5.0 mL DiI. Invert tube several times to
mix.
4. Cover tube to avoid light exposure. Place tube on shaker table set for ~60 rpm, and allow to
shake for 1-3 hours.
5. Remove tube from shaker table and pipette off supernatant. Rinse in 1 mL M9 buffer.
Repeat at least once.
6. Pipette worms onto an NGM streak plate. Allow 12-24 hours before imaging, if worms are
to be used for confocal analysis.
7. Dye filling worms will have visibly red amphid and phasmid neurons, clearly distinguishable
by their dendrites. Non-dye filling worms will show only intestinal fluorescence.
Appendix B: Cas9 Purification
Unless otherwise noted, all steps should be done on ice or at 4oC.
1. Prepare the following buffers prior to purification. All buffers are made with Milli-Q water.
Dry ingredients should be added and dissolved first in Milli-Q, and the solution should be
brought to the correct pH prior to adding glycerol and bringing the buffer to its final volume
a. Buffer A (100 mL): 20mM Tris HCl pH 8.0, 250 mM KCl, 20 mM imidazole, 10%
glycerol, 1 mM TCEP.
b. Buffer B (100 mL): 20mM Tris HCl pH 8.0, 800 mM KCl, 20 mM imidazole, 10%
glycerol, 1 mM TCEP.
c. Buffer C* (100 mL): 20mM Hepes pH 8.0, 500 mM KCl, 500 mM imidazole*, 10%
glycerol
d. Buffer D (2L): 20mM Hepes pH 8.0, 500 mM KCl, 20% glycerol
e. Buffer R1* (50 mL): 1M KCl, 1M imidazole
f. Buffer R2* (50 mL): 1M KCl, 1M imidazole, 2M urea
2. Plate DE3 GOLD (Agilent, #230132) cells with nm2973 plasmid (Fu et al. 2014) and plate
on LB + 50 µg/mL Carbenicillin. Grow overnight at 37o C; plate can then be kept for several
weeks at 4oC.
3. Inoculate 25 mL LB + 50 µg/mL Carbenicillin with a single colony from the fresh plate.
Incubate at 37oC overnight.
4. Transfer 5 mL of overnight culture to 1L LB + 0.1% glucose + 50 µg/mL Carbenicillin and
grow at 25oC (220 rpm). Grow culture to OD600 ≈ 0.5.
5. Shift culture to 18oC for 15-25 minutes, then add IPTG to 0.2 mM. It is best to measure out
the IPTG into a small Eppendorf tube and add Milli-Q water to dissolve it just before adding
it to the culture. Incubate overnight.
6. Make a solution of 100 mM PMSF in 1 mL EtOH.
7. Pellet culture in sterile 250 mL centrifuge bottles using F14S – 6X250Y rotor at 5000 rpm
and 4oC. Obtain wet weight, and resuspend each pellet at ~6 mL/g cells with Buffer A +
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protease inhibitor (4 tablets/10 mL, Roche, #11836170001) + 1mM PMSF solution.
Combine all samples in two 50 mL falcon tubes.
8. Sonicate cells 6 x 45s with a 1 second pulse/2 second pause at 30% amplitude. Alternate
falcon tubes, and allow for 1 minute cooling between each cycle. Tubes should be kept on
ice or in an ice bath, and excess bubble production should be avoided by keeping the
sonicator tip off the tube wall to maximize sonication efficiency.
9. Recombine lysate and split evenly between two sterile Oakridge tubes. Spin lysate for 30
minutes at 16000 rpm and 4oC in SS34 rotor.
10. During spin step, place a sterile filter in the base of a 5 ml column and seal the side openings
of the stopcock with Parafilm. Pipette 5 mL of Ni-agarose beads (50% slurry) into two small
falcon tubes, and equilibrate with buffer A by filling the falcon tube to the top with buffer,
spinning the beads down for 60 s at 3000 rpm, and removing the supernatant. Repeat
equilibration two more times
11. Transfer clarified lysate to a fresh falcon tube and add beads. Batch bind Ni beads for ~25
minutes*.
12. Pipette the nickel beads into the column evenly so that they form a flat layer in the base of
the column. Wash these with 50-100 mL* of Buffer B.
13. Elute protein with buffer C, collecting 25 1mL fractions in separate Eppendorf tubes.
14. Run fractions on SDS page gel to determine which fractions contain Cas9 protein, which
appears as a large band at 160 kDa. Pool fractions containing Cas9 protein.
15. Prepare a second 5 mL column with a sterile filter and sealed stopcock. Pipette 10 mL
Sepharose beads (50% slurry) into the column, and equilibrate with 1M KCl (25 mL) to
charge the column, followed by buffer C (25 mL).
16. Flow eluent over Sepharose column and collect in a falcon tube. Dialyze in 1L of Buffer D
for at least 5 hours* using a Pierce Cassette. Transfer the cassette to fresh Buffer D (1L) and
dialyze overnight.
17. Concentrate protein to ~10mg/mL using a 100K centrifugal filter (Milipore, UFO910024).
Centrifuge the eluent for 10 minutes at a time at 5,000 rpm and 4oC until the desired
concentration is reached. A Nanodrop 2000 or Bradford Assay can be used to determine
final concentrations.
18. Pipette 5 µl aliquots into PCR tubes and flash-freeze the concentrated protein using dry ice
bath and store at -80oC.
19. Note that Ni beads can be regenerated as follows:
a. Run R1 buffer over the column (50 mL)
b. Run R2 buffer over the column (50 mL)
c. Run sterile H2O over the column (50 mL)
d. Run 20% EtOH over the column (50 mL)
e. Store beads in EtOH at 4oC.
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